id	sid	tid	token	lemma	pos
ajmpe-878	1	1	american	american	PROPN
ajmpe-878	1	2	journal	journal	PROPN
ajmpe-878	1	3	of	of	ADP
ajmpe-878	1	4	medical	medical	ADJ
ajmpe-878	1	5	and	and	CCONJ
ajmpe-878	1	6	physical	physical	ADJ
ajmpe-878	1	7	education	education	NOUN
ajmpe-878	1	8	vol.9	vol.9	PROPN
ajmpe-878	1	9	,	,	PUNCT
ajmpe-878	1	10	issue	issue	NOUN
ajmpe-878	1	11	1	1	NUM
ajmpe-878	1	12	;	;	PUNCT
ajmpe-878	1	13	january	january	PROPN
ajmpe-878	1	14	-	-	PUNCT
ajmpe-878	1	15	february	february	PROPN
ajmpe-878	1	16	2024	2024	NUM
ajmpe-878	1	17	;	;	PUNCT
ajmpe-878	1	18	issn	issn	PROPN
ajmpe-878	1	19	:	:	PUNCT
ajmpe-878	1	20	2994	2994	NUM
ajmpe-878	1	21	-	-	SYM
ajmpe-878	1	22	0524	0524	NUM
ajmpe-878	1	23	impact	impact	NOUN
ajmpe-878	1	24	factor	factor	NOUN
ajmpe-878	1	25	:	:	PUNCT
ajmpe-878	1	26	6.14	6.14	NUM
ajmpe-878	1	27	1252	1252	NUM
ajmpe-878	1	28	columbia	columbia	PROPN
ajmpe-878	1	29	rd	rd	PROPN
ajmpe-878	1	30	nw	nw	PROPN
ajmpe-878	1	31	,	,	PUNCT
ajmpe-878	1	32	washington	washington	PROPN
ajmpe-878	1	33	dc	dc	PROPN
ajmpe-878	1	34	,	,	PUNCT
ajmpe-878	1	35	united	united	PROPN
ajmpe-878	1	36	states	states	PROPN
ajmpe-878	1	37	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	1	38	;	;	PUNCT
ajmpe-878	1	39	mail	mail	NOUN
ajmpe-878	1	40	:	:	PUNCT
ajmpe-878	1	41	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	2	1	1	1	NUM
ajmpe-878	3	1	|	|	ADV
ajmpe-878	3	2	a	a	DET
ajmpe-878	3	3	m	m	NOUN
ajmpe-878	3	4	e	e	NOUN
ajmpe-878	3	5	r	r	NOUN
ajmpe-878	4	1	i	i	NOUN
ajmpe-878	4	2	c	c	VERB
ajmpe-878	4	3	a	a	DET
ajmpe-878	4	4	n	n	NOUN
ajmpe-878	5	1	j	j	NOUN
ajmpe-878	5	2	o	o	X
ajmpe-878	5	3	u	u	NOUN
ajmpe-878	5	4	r	r	NOUN
ajmpe-878	5	5	n	n	NOUN
ajmpe-878	5	6	a	a	DET
ajmpe-878	5	7	l	l	NOUN
ajmpe-878	5	8	o	o	X
ajmpe-878	6	1	f	f	X
ajmpe-878	6	2	m	m	NOUN
ajmpe-878	6	3	e	e	NOUN
ajmpe-878	7	1	d	d	NOUN
ajmpe-878	7	2	i	i	PRON
ajmpe-878	7	3	c	c	VERB
ajmpe-878	7	4	a	a	DET
ajmpe-878	7	5	l	l	NOUN
ajmpe-878	7	6	a	a	X
ajmpe-878	7	7	n	n	NOUN
ajmpe-878	8	1	d	d	NOUN
ajmpe-878	8	2	p	p	NOUN
ajmpe-878	8	3	h	h	NOUN
ajmpe-878	8	4	y	y	NOUN
ajmpe-878	8	5	s	s	VERB
ajmpe-878	9	1	i	i	INTJ
ajmpe-878	9	2	c	c	VERB
ajmpe-878	9	3	a	a	DET
ajmpe-878	9	4	l	l	NOUN
ajmpe-878	9	5	e	e	NOUN
ajmpe-878	9	6	d	d	X
ajmpe-878	9	7	u	u	X
ajmpe-878	9	8	c	c	PROPN
ajmpe-878	10	1	a	a	DET
ajmpe-878	10	2	t	t	NOUN
ajmpe-878	11	1	i	i	PRON
ajmpe-878	11	2	o	o	VERB
ajmpe-878	11	3	n	n	CCONJ
ajmpe-878	11	4	|	|	ADV
ajmpe-878	11	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	11	6	from	from	ADP
ajmpe-878	11	7	silence	silence	NOUN
ajmpe-878	11	8	to	to	ADP
ajmpe-878	11	9	resurgence	resurgence	NOUN
ajmpe-878	11	10	:	:	PUNCT
ajmpe-878	11	11	tuberculosis	tuberculosis	ADP
ajmpe-878	11	12	reactivation	reactivation	NOUN
ajmpe-878	11	13	following	follow	VERB
ajmpe-878	11	14	covid-19	covid-19	PROPN
ajmpe-878	11	15	–	–	PUNCT
ajmpe-878	11	16	a	a	DET
ajmpe-878	11	17	singular	singular	ADJ
ajmpe-878	11	18	case	case	NOUN
ajmpe-878	11	19	analysis	analysis	NOUN
ajmpe-878	11	20	1nino	1nino	NUM
ajmpe-878	11	21	g.	g.	NOUN
ajmpe-878	11	22	javakhishvili	javakhishvili	NOUN
ajmpe-878	11	23	,	,	PUNCT
ajmpe-878	11	24	2david	2david	NUM
ajmpe-878	11	25	l.	l.	NOUN
ajmpe-878	11	26	kipshidze	kipshidze	PROPN
ajmpe-878	11	27	and	and	CCONJ
ajmpe-878	11	28	3mariam	3mariam	NUM
ajmpe-878	11	29	n.	n.	NOUN
ajmpe-878	11	30	abashidze	abashidze	PROPN
ajmpe-878	12	1	1department	1department	NUM
ajmpe-878	12	2	of	of	ADP
ajmpe-878	12	3	infectious	infectious	ADJ
ajmpe-878	12	4	disease	disease	NOUN
ajmpe-878	12	5	,	,	PUNCT
ajmpe-878	12	6	tbilisi	tbilisi	PROPN
ajmpe-878	12	7	state	state	PROPN
ajmpe-878	12	8	medical	medical	PROPN
ajmpe-878	12	9	university	university	PROPN
ajmpe-878	12	10	,	,	PUNCT
ajmpe-878	12	11	tbilisi	tbilisi	PROPN
ajmpe-878	12	12	,	,	PUNCT
ajmpe-878	12	13	georgia	georgia	PROPN
ajmpe-878	12	14	2intensive	2intensive	NUM
ajmpe-878	12	15	care	care	NOUN
ajmpe-878	12	16	unit	unit	NOUN
ajmpe-878	12	17	,	,	PUNCT
ajmpe-878	12	18	tbilisi	tbilisi	PROPN
ajmpe-878	12	19	state	state	PROPN
ajmpe-878	12	20	medical	medical	PROPN
ajmpe-878	12	21	university	university	PROPN
ajmpe-878	12	22	,	,	PUNCT
ajmpe-878	12	23	tbilisi	tbilisi	PROPN
ajmpe-878	12	24	,	,	PUNCT
ajmpe-878	12	25	georgia	georgia	PROPN
ajmpe-878	12	26	3department	3department	NUM
ajmpe-878	12	27	of	of	ADP
ajmpe-878	12	28	neurology	neurology	NOUN
ajmpe-878	12	29	,	,	PUNCT
ajmpe-878	12	30	tbilisi	tbilisi	PROPN
ajmpe-878	12	31	state	state	PROPN
ajmpe-878	12	32	medical	medical	PROPN
ajmpe-878	12	33	university	university	PROPN
ajmpe-878	12	34	,	,	PUNCT
ajmpe-878	12	35	tbilisi	tbilisi	PROPN
ajmpe-878	12	36	,	,	PUNCT
ajmpe-878	12	37	georgia	georgia	PROPN
ajmpe-878	12	38	.	.	PUNCT
ajmpe-878	13	1	doi	doi	PROPN
ajmpe-878	13	2	:	:	PUNCT
ajmpe-878	13	3	https://doi.org/10.5281/zenodo.10598098	https://doi.org/10.5281/zenodo.10598098	PROPN
ajmpe-878	13	4	abstract	abstract	NOUN
ajmpe-878	13	5	:	:	PUNCT
ajmpe-878	13	6	tuberculosis	tuberculosis	NOUN
ajmpe-878	13	7	(	(	PUNCT
ajmpe-878	13	8	tb	tb	NOUN
ajmpe-878	13	9	)	)	PUNCT
ajmpe-878	13	10	stands	stand	VERB
ajmpe-878	13	11	as	as	ADP
ajmpe-878	13	12	a	a	DET
ajmpe-878	13	13	prominent	prominent	ADJ
ajmpe-878	13	14	global	global	ADJ
ajmpe-878	13	15	health	health	NOUN
ajmpe-878	13	16	threat	threat	NOUN
ajmpe-878	13	17	,	,	PUNCT
ajmpe-878	13	18	persisting	persist	VERB
ajmpe-878	13	19	as	as	ADP
ajmpe-878	13	20	a	a	DET
ajmpe-878	13	21	leading	lead	VERB
ajmpe-878	13	22	cause	cause	NOUN
ajmpe-878	13	23	of	of	ADP
ajmpe-878	13	24	mortality	mortality	NOUN
ajmpe-878	13	25	on	on	ADP
ajmpe-878	13	26	a	a	DET
ajmpe-878	13	27	worldwide	worldwide	ADJ
ajmpe-878	13	28	scale	scale	NOUN
ajmpe-878	13	29	(	(	PUNCT
ajmpe-878	13	30	world	world	NOUN
ajmpe-878	13	31	health	health	NOUN
ajmpe-878	13	32	organization	organization	NOUN
ajmpe-878	13	33	,	,	PUNCT
ajmpe-878	13	34	2022a	2022a	NUM
ajmpe-878	13	35	)	)	PUNCT
ajmpe-878	13	36	.	.	PUNCT
ajmpe-878	14	1	caused	cause	VERB
ajmpe-878	14	2	by	by	ADP
ajmpe-878	14	3	the	the	DET
ajmpe-878	14	4	infectious	infectious	ADJ
ajmpe-878	14	5	agent	agent	NOUN
ajmpe-878	14	6	mycobacterium	mycobacterium	NOUN
ajmpe-878	14	7	tuberculosis	tuberculosis	NOUN
ajmpe-878	14	8	,	,	PUNCT
ajmpe-878	14	9	tb	tb	ADP
ajmpe-878	14	10	spreads	spread	NOUN
ajmpe-878	14	11	through	through	ADP
ajmpe-878	14	12	respiratory	respiratory	ADJ
ajmpe-878	14	13	droplets	droplet	NOUN
ajmpe-878	14	14	when	when	SCONJ
ajmpe-878	14	15	an	an	DET
ajmpe-878	14	16	infected	infected	ADJ
ajmpe-878	14	17	individual	individual	ADJ
ajmpe-878	14	18	coughs	cough	NOUN
ajmpe-878	14	19	or	or	CCONJ
ajmpe-878	14	20	sneezes	sneeze	VERB
ajmpe-878	14	21	.	.	PUNCT
ajmpe-878	15	1	while	while	SCONJ
ajmpe-878	15	2	primarily	primarily	ADV
ajmpe-878	15	3	affecting	affect	VERB
ajmpe-878	15	4	the	the	DET
ajmpe-878	15	5	lungs	lung	NOUN
ajmpe-878	15	6	,	,	PUNCT
ajmpe-878	15	7	tb	tb	X
ajmpe-878	15	8	can	can	AUX
ajmpe-878	15	9	extend	extend	VERB
ajmpe-878	15	10	its	its	PRON
ajmpe-878	15	11	impact	impact	NOUN
ajmpe-878	15	12	to	to	ADP
ajmpe-878	15	13	various	various	ADJ
ajmpe-878	15	14	organs	organ	NOUN
ajmpe-878	15	15	and	and	CCONJ
ajmpe-878	15	16	systems	system	NOUN
ajmpe-878	15	17	within	within	ADP
ajmpe-878	15	18	the	the	DET
ajmpe-878	15	19	body	body	NOUN
ajmpe-878	15	20	(	(	PUNCT
ajmpe-878	15	21	centers	center	NOUN
ajmpe-878	15	22	for	for	ADP
ajmpe-878	15	23	disease	disease	NOUN
ajmpe-878	15	24	control	control	NOUN
ajmpe-878	15	25	and	and	CCONJ
ajmpe-878	15	26	prevention	prevention	NOUN
ajmpe-878	15	27	,	,	PUNCT
ajmpe-878	15	28	2022	2022	NUM
ajmpe-878	15	29	)	)	PUNCT
ajmpe-878	15	30	.	.	PUNCT
ajmpe-878	16	1	this	this	DET
ajmpe-878	16	2	research	research	NOUN
ajmpe-878	16	3	aims	aim	VERB
ajmpe-878	16	4	to	to	PART
ajmpe-878	16	5	shed	shed	VERB
ajmpe-878	16	6	light	light	NOUN
ajmpe-878	16	7	on	on	ADP
ajmpe-878	16	8	the	the	DET
ajmpe-878	16	9	diverse	diverse	ADJ
ajmpe-878	16	10	facets	facet	NOUN
ajmpe-878	16	11	of	of	ADP
ajmpe-878	16	12	tb	tb	NOUN
ajmpe-878	16	13	,	,	PUNCT
ajmpe-878	16	14	focusing	focus	VERB
ajmpe-878	16	15	on	on	ADP
ajmpe-878	16	16	its	its	PRON
ajmpe-878	16	17	two	two	NUM
ajmpe-878	16	18	principal	principal	ADJ
ajmpe-878	16	19	manifestations	manifestation	NOUN
ajmpe-878	16	20	:	:	PUNCT
ajmpe-878	16	21	latent	latent	NOUN
ajmpe-878	16	22	tb	tb	ADP
ajmpe-878	16	23	infection	infection	NOUN
ajmpe-878	16	24	and	and	CCONJ
ajmpe-878	16	25	active	active	ADJ
ajmpe-878	16	26	tb	tb	ADP
ajmpe-878	16	27	disease	disease	NOUN
ajmpe-878	16	28	.	.	PUNCT
ajmpe-878	17	1	latent	latent	NOUN
ajmpe-878	17	2	tb	tb	ADP
ajmpe-878	17	3	infection	infection	NOUN
ajmpe-878	17	4	characterizes	characterize	VERB
ajmpe-878	17	5	individuals	individual	NOUN
ajmpe-878	17	6	who	who	PRON
ajmpe-878	17	7	carry	carry	VERB
ajmpe-878	17	8	the	the	DET
ajmpe-878	17	9	tb	tb	NOUN
ajmpe-878	17	10	bacteria	bacteria	NOUN
ajmpe-878	17	11	but	but	CCONJ
ajmpe-878	17	12	remain	remain	VERB
ajmpe-878	17	13	asymptomatic	asymptomatic	ADJ
ajmpe-878	17	14	and	and	CCONJ
ajmpe-878	17	15	do	do	AUX
ajmpe-878	17	16	not	not	PART
ajmpe-878	17	17	transmit	transmit	VERB
ajmpe-878	17	18	the	the	DET
ajmpe-878	17	19	disease	disease	NOUN
ajmpe-878	17	20	.	.	PUNCT
ajmpe-878	18	1	however	however	ADV
ajmpe-878	18	2	,	,	PUNCT
ajmpe-878	18	3	the	the	DET
ajmpe-878	18	4	latent	latent	NOUN
ajmpe-878	18	5	form	form	NOUN
ajmpe-878	18	6	poses	pose	VERB
ajmpe-878	18	7	a	a	DET
ajmpe-878	18	8	risk	risk	NOUN
ajmpe-878	18	9	of	of	ADP
ajmpe-878	18	10	progressing	progress	VERB
ajmpe-878	18	11	into	into	ADP
ajmpe-878	18	12	active	active	ADJ
ajmpe-878	18	13	tb	tb	ADP
ajmpe-878	18	14	disease	disease	NOUN
ajmpe-878	18	15	,	,	PUNCT
ajmpe-878	18	16	particularly	particularly	ADV
ajmpe-878	18	17	in	in	ADP
ajmpe-878	18	18	cases	case	NOUN
ajmpe-878	18	19	where	where	SCONJ
ajmpe-878	18	20	the	the	DET
ajmpe-878	18	21	individual	individual	NOUN
ajmpe-878	18	22	's	's	PART
ajmpe-878	18	23	immune	immune	ADJ
ajmpe-878	18	24	system	system	NOUN
ajmpe-878	18	25	becomes	become	VERB
ajmpe-878	18	26	compromised	compromise	VERB
ajmpe-878	18	27	(	(	PUNCT
ajmpe-878	18	28	centers	center	NOUN
ajmpe-878	18	29	for	for	ADP
ajmpe-878	18	30	disease	disease	NOUN
ajmpe-878	18	31	control	control	NOUN
ajmpe-878	18	32	and	and	CCONJ
ajmpe-878	18	33	prevention	prevention	NOUN
ajmpe-878	18	34	)	)	PUNCT
ajmpe-878	18	35	.	.	PUNCT
ajmpe-878	19	1	the	the	DET
ajmpe-878	19	2	urgency	urgency	NOUN
ajmpe-878	19	3	of	of	ADP
ajmpe-878	19	4	addressing	address	VERB
ajmpe-878	19	5	tb	tb	NOUN
ajmpe-878	19	6	is	be	AUX
ajmpe-878	19	7	underscored	underscore	VERB
ajmpe-878	19	8	by	by	ADP
ajmpe-878	19	9	its	its	PRON
ajmpe-878	19	10	potential	potential	NOUN
ajmpe-878	19	11	to	to	AUX
ajmpe-878	19	12	transition	transition	NOUN
ajmpe-878	19	13	from	from	ADP
ajmpe-878	19	14	latent	latent	NOUN
ajmpe-878	19	15	to	to	ADP
ajmpe-878	19	16	active	active	ADJ
ajmpe-878	19	17	,	,	PUNCT
ajmpe-878	19	18	thereby	thereby	ADV
ajmpe-878	19	19	elevating	elevate	VERB
ajmpe-878	19	20	the	the	DET
ajmpe-878	19	21	risk	risk	NOUN
ajmpe-878	19	22	of	of	ADP
ajmpe-878	19	23	transmission	transmission	NOUN
ajmpe-878	19	24	and	and	CCONJ
ajmpe-878	19	25	severe	severe	ADJ
ajmpe-878	19	26	health	health	NOUN
ajmpe-878	19	27	consequences	consequence	NOUN
ajmpe-878	19	28	.	.	PUNCT
ajmpe-878	20	1	the	the	DET
ajmpe-878	20	2	study	study	NOUN
ajmpe-878	20	3	delves	delve	VERB
ajmpe-878	20	4	into	into	ADP
ajmpe-878	20	5	the	the	DET
ajmpe-878	20	6	dynamics	dynamic	NOUN
ajmpe-878	20	7	of	of	ADP
ajmpe-878	20	8	tb	tb	ADP
ajmpe-878	20	9	infection	infection	NOUN
ajmpe-878	20	10	,	,	PUNCT
ajmpe-878	20	11	emphasizing	emphasize	VERB
ajmpe-878	20	12	the	the	DET
ajmpe-878	20	13	critical	critical	ADJ
ajmpe-878	20	14	importance	importance	NOUN
ajmpe-878	20	15	of	of	ADP
ajmpe-878	20	16	early	early	ADJ
ajmpe-878	20	17	detection	detection	NOUN
ajmpe-878	20	18	and	and	CCONJ
ajmpe-878	20	19	intervention	intervention	NOUN
ajmpe-878	20	20	to	to	PART
ajmpe-878	20	21	mitigate	mitigate	VERB
ajmpe-878	20	22	the	the	DET
ajmpe-878	20	23	escalation	escalation	NOUN
ajmpe-878	20	24	from	from	ADP
ajmpe-878	20	25	latent	latent	NOUN
ajmpe-878	20	26	to	to	ADP
ajmpe-878	20	27	active	active	ADJ
ajmpe-878	20	28	tb	tb	NOUN
ajmpe-878	20	29	.	.	PUNCT
ajmpe-878	21	1	furthermore	furthermore	ADV
ajmpe-878	21	2	,	,	PUNCT
ajmpe-878	21	3	it	it	PRON
ajmpe-878	21	4	explores	explore	VERB
ajmpe-878	21	5	factors	factor	NOUN
ajmpe-878	21	6	contributing	contribute	VERB
ajmpe-878	21	7	to	to	ADP
ajmpe-878	21	8	the	the	DET
ajmpe-878	21	9	weakening	weakening	NOUN
ajmpe-878	21	10	of	of	ADP
ajmpe-878	21	11	the	the	DET
ajmpe-878	21	12	immune	immune	ADJ
ajmpe-878	21	13	system	system	NOUN
ajmpe-878	21	14	,	,	PUNCT
ajmpe-878	21	15	which	which	PRON
ajmpe-878	21	16	serves	serve	VERB
ajmpe-878	21	17	as	as	ADP
ajmpe-878	21	18	a	a	DET
ajmpe-878	21	19	pivotal	pivotal	ADJ
ajmpe-878	21	20	link	link	NOUN
ajmpe-878	21	21	between	between	ADP
ajmpe-878	21	22	latent	latent	NOUN
ajmpe-878	21	23	tb	tb	X
ajmpe-878	21	24	and	and	CCONJ
ajmpe-878	21	25	the	the	DET
ajmpe-878	21	26	development	development	NOUN
ajmpe-878	21	27	of	of	ADP
ajmpe-878	21	28	active	active	ADJ
ajmpe-878	21	29	disease	disease	NOUN
ajmpe-878	21	30	.	.	PUNCT
ajmpe-878	22	1	by	by	ADP
ajmpe-878	22	2	elucidating	elucidate	VERB
ajmpe-878	22	3	the	the	DET
ajmpe-878	22	4	intricate	intricate	ADJ
ajmpe-878	22	5	interplay	interplay	NOUN
ajmpe-878	22	6	between	between	ADP
ajmpe-878	22	7	latent	latent	NOUN
ajmpe-878	22	8	and	and	CCONJ
ajmpe-878	22	9	active	active	ADJ
ajmpe-878	22	10	tb	tb	NOUN
ajmpe-878	22	11	,	,	PUNCT
ajmpe-878	22	12	this	this	DET
ajmpe-878	22	13	research	research	NOUN
ajmpe-878	22	14	not	not	PART
ajmpe-878	22	15	only	only	ADV
ajmpe-878	22	16	contributes	contribute	VERB
ajmpe-878	22	17	to	to	ADP
ajmpe-878	22	18	a	a	DET
ajmpe-878	22	19	deeper	deep	ADJ
ajmpe-878	22	20	understanding	understanding	NOUN
ajmpe-878	22	21	of	of	ADP
ajmpe-878	22	22	the	the	DET
ajmpe-878	22	23	disease	disease	NOUN
ajmpe-878	22	24	but	but	CCONJ
ajmpe-878	22	25	also	also	ADV
ajmpe-878	22	26	provides	provide	VERB
ajmpe-878	22	27	insights	insight	NOUN
ajmpe-878	22	28	crucial	crucial	ADJ
ajmpe-878	22	29	for	for	ADP
ajmpe-878	22	30	public	public	ADJ
ajmpe-878	22	31	health	health	NOUN
ajmpe-878	22	32	strategies	strategy	NOUN
ajmpe-878	22	33	and	and	CCONJ
ajmpe-878	22	34	interventions	intervention	NOUN
ajmpe-878	22	35	.	.	PUNCT
ajmpe-878	23	1	the	the	DET
ajmpe-878	23	2	overarching	overarching	ADJ
ajmpe-878	23	3	goal	goal	NOUN
ajmpe-878	23	4	is	be	AUX
ajmpe-878	23	5	to	to	PART
ajmpe-878	23	6	inform	inform	VERB
ajmpe-878	23	7	targeted	target	VERB
ajmpe-878	23	8	measures	measure	NOUN
ajmpe-878	23	9	that	that	PRON
ajmpe-878	23	10	can	can	AUX
ajmpe-878	23	11	effectively	effectively	ADV
ajmpe-878	23	12	curb	curb	VERB
ajmpe-878	23	13	the	the	DET
ajmpe-878	23	14	spread	spread	NOUN
ajmpe-878	23	15	of	of	ADP
ajmpe-878	23	16	tb	tb	NOUN
ajmpe-878	23	17	and	and	CCONJ
ajmpe-878	23	18	reduce	reduce	VERB
ajmpe-878	23	19	its	its	PRON
ajmpe-878	23	20	impact	impact	NOUN
ajmpe-878	23	21	on	on	ADP
ajmpe-878	23	22	global	global	ADJ
ajmpe-878	23	23	health	health	NOUN
ajmpe-878	23	24	.	.	PUNCT
ajmpe-878	24	1	keywords	keyword	NOUN
ajmpe-878	24	2	:	:	PUNCT
ajmpe-878	24	3	tuberculosis	tuberculosis	NOUN
ajmpe-878	24	4	(	(	PUNCT
ajmpe-878	24	5	tb	tb	NOUN
ajmpe-878	24	6	)	)	PUNCT
ajmpe-878	24	7	,	,	PUNCT
ajmpe-878	24	8	latent	latent	NOUN
ajmpe-878	24	9	tb	tb	ADP
ajmpe-878	24	10	infection	infection	NOUN
ajmpe-878	24	11	,	,	PUNCT
ajmpe-878	24	12	active	active	ADJ
ajmpe-878	24	13	tb	tb	ADP
ajmpe-878	24	14	disease	disease	NOUN
ajmpe-878	24	15	,	,	PUNCT
ajmpe-878	24	16	mycobacterium	mycobacterium	NOUN
ajmpe-878	24	17	tuberculosis	tuberculosis	NOUN
ajmpe-878	24	18	,	,	PUNCT
ajmpe-878	24	19	immune	immune	ADJ
ajmpe-878	24	20	system	system	NOUN
ajmpe-878	24	21	compromise	compromise	NOUN
ajmpe-878	24	22	introduction	introduction	NOUN
ajmpe-878	24	23	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-878	24	24	american	american	PROPN
ajmpe-878	24	25	journal	journal	PROPN
ajmpe-878	24	26	of	of	ADP
ajmpe-878	24	27	medical	medical	ADJ
ajmpe-878	24	28	and	and	CCONJ
ajmpe-878	24	29	physical	physical	ADJ
ajmpe-878	24	30	education	education	NOUN
ajmpe-878	24	31	vol.9	vol.9	PROPN
ajmpe-878	24	32	,	,	PUNCT
ajmpe-878	24	33	issue	issue	NOUN
ajmpe-878	24	34	1	1	NUM
ajmpe-878	24	35	;	;	PUNCT
ajmpe-878	24	36	january	january	PROPN
ajmpe-878	24	37	-	-	PUNCT
ajmpe-878	24	38	february	february	PROPN
ajmpe-878	24	39	2024	2024	NUM
ajmpe-878	24	40	;	;	PUNCT
ajmpe-878	24	41	issn	issn	PROPN
ajmpe-878	24	42	:	:	PUNCT
ajmpe-878	24	43	2994	2994	NUM
ajmpe-878	24	44	-	-	SYM
ajmpe-878	24	45	0524	0524	NUM
ajmpe-878	24	46	impact	impact	NOUN
ajmpe-878	24	47	factor	factor	NOUN
ajmpe-878	24	48	:	:	PUNCT
ajmpe-878	24	49	6.14	6.14	NUM
ajmpe-878	24	50	1252	1252	NUM
ajmpe-878	24	51	columbia	columbia	PROPN
ajmpe-878	24	52	rd	rd	PROPN
ajmpe-878	24	53	nw	nw	PROPN
ajmpe-878	24	54	,	,	PUNCT
ajmpe-878	24	55	washington	washington	PROPN
ajmpe-878	24	56	dc	dc	PROPN
ajmpe-878	24	57	,	,	PUNCT
ajmpe-878	24	58	united	united	PROPN
ajmpe-878	24	59	states	states	PROPN
ajmpe-878	24	60	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	24	61	;	;	PUNCT
ajmpe-878	24	62	mail	mail	NOUN
ajmpe-878	24	63	:	:	PUNCT
ajmpe-878	24	64	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	25	1	2	2	NUM
ajmpe-878	26	1	|	|	ADV
ajmpe-878	26	2	a	a	DET
ajmpe-878	26	3	m	m	NOUN
ajmpe-878	26	4	e	e	NOUN
ajmpe-878	26	5	r	r	NOUN
ajmpe-878	26	6	i	i	NOUN
ajmpe-878	26	7	c	c	VERB
ajmpe-878	26	8	a	a	DET
ajmpe-878	26	9	n	n	NOUN
ajmpe-878	27	1	j	j	NOUN
ajmpe-878	27	2	o	o	X
ajmpe-878	27	3	u	u	NOUN
ajmpe-878	27	4	r	r	NOUN
ajmpe-878	27	5	n	n	NOUN
ajmpe-878	27	6	a	a	DET
ajmpe-878	27	7	l	l	NOUN
ajmpe-878	27	8	o	o	X
ajmpe-878	28	1	f	f	X
ajmpe-878	28	2	m	m	NOUN
ajmpe-878	28	3	e	e	NOUN
ajmpe-878	29	1	d	d	NOUN
ajmpe-878	29	2	i	i	PRON
ajmpe-878	29	3	c	c	VERB
ajmpe-878	29	4	a	a	DET
ajmpe-878	29	5	l	l	NOUN
ajmpe-878	29	6	a	a	X
ajmpe-878	29	7	n	n	NOUN
ajmpe-878	30	1	d	d	NOUN
ajmpe-878	30	2	p	p	NOUN
ajmpe-878	30	3	h	h	NOUN
ajmpe-878	30	4	y	y	NOUN
ajmpe-878	30	5	s	s	VERB
ajmpe-878	31	1	i	i	INTJ
ajmpe-878	31	2	c	c	VERB
ajmpe-878	31	3	a	a	DET
ajmpe-878	31	4	l	l	NOUN
ajmpe-878	31	5	e	e	NOUN
ajmpe-878	31	6	d	d	X
ajmpe-878	31	7	u	u	X
ajmpe-878	31	8	c	c	PROPN
ajmpe-878	32	1	a	a	DET
ajmpe-878	32	2	t	t	NOUN
ajmpe-878	33	1	i	i	PRON
ajmpe-878	33	2	o	o	VERB
ajmpe-878	33	3	n	n	CCONJ
ajmpe-878	33	4	|	|	ADV
ajmpe-878	33	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-878	33	6	tuberculosis	tuberculosis	NOUN
ajmpe-878	33	7	(	(	PUNCT
ajmpe-878	33	8	tb	tb	NOUN
ajmpe-878	33	9	)	)	PUNCT
ajmpe-878	33	10	is	be	AUX
ajmpe-878	33	11	a	a	DET
ajmpe-878	33	12	significant	significant	ADJ
ajmpe-878	33	13	global	global	ADJ
ajmpe-878	33	14	health	health	NOUN
ajmpe-878	33	15	concern	concern	NOUN
ajmpe-878	33	16	and	and	CCONJ
ajmpe-878	33	17	remains	remain	VERB
ajmpe-878	33	18	one	one	NUM
ajmpe-878	33	19	of	of	ADP
ajmpe-878	33	20	the	the	DET
ajmpe-878	33	21	leading	lead	VERB
ajmpe-878	33	22	causes	cause	NOUN
ajmpe-878	33	23	of	of	ADP
ajmpe-878	33	24	death	death	NOUN
ajmpe-878	33	25	worldwide	worldwide	ADV
ajmpe-878	33	26	(	(	PUNCT
ajmpe-878	33	27	world	world	NOUN
ajmpe-878	33	28	health	health	NOUN
ajmpe-878	33	29	organization	organization	NOUN
ajmpe-878	33	30	,	,	PUNCT
ajmpe-878	33	31	2022a	2022a	NUM
ajmpe-878	33	32	)	)	PUNCT
ajmpe-878	33	33	.	.	PUNCT
ajmpe-878	34	1	it	it	PRON
ajmpe-878	34	2	is	be	AUX
ajmpe-878	34	3	an	an	DET
ajmpe-878	34	4	infectious	infectious	ADJ
ajmpe-878	34	5	disease	disease	NOUN
ajmpe-878	34	6	caused	cause	VERB
ajmpe-878	34	7	by	by	ADP
ajmpe-878	34	8	the	the	DET
ajmpe-878	34	9	mycobacterium	mycobacterium	NOUN
ajmpe-878	34	10	tuberculosis	tuberculosis	NOUN
ajmpe-878	34	11	.	.	PUNCT
ajmpe-878	35	1	tb	tb	NOUN
ajmpe-878	35	2	is	be	AUX
ajmpe-878	35	3	spread	spread	VERB
ajmpe-878	35	4	through	through	ADP
ajmpe-878	35	5	the	the	DET
ajmpe-878	35	6	air	air	NOUN
ajmpe-878	35	7	when	when	SCONJ
ajmpe-878	35	8	an	an	DET
ajmpe-878	35	9	infected	infected	ADJ
ajmpe-878	35	10	person	person	NOUN
ajmpe-878	35	11	coughs	cough	NOUN
ajmpe-878	35	12	or	or	CCONJ
ajmpe-878	35	13	sneezes	sneeze	VERB
ajmpe-878	35	14	.	.	PUNCT
ajmpe-878	36	1	it	it	PRON
ajmpe-878	36	2	primarily	primarily	ADV
ajmpe-878	36	3	affects	affect	VERB
ajmpe-878	36	4	the	the	DET
ajmpe-878	36	5	lungs	lung	NOUN
ajmpe-878	36	6	,	,	PUNCT
ajmpe-878	36	7	but	but	CCONJ
ajmpe-878	36	8	can	can	AUX
ajmpe-878	36	9	also	also	ADV
ajmpe-878	36	10	affect	affect	VERB
ajmpe-878	36	11	other	other	ADJ
ajmpe-878	36	12	parts	part	NOUN
ajmpe-878	36	13	of	of	ADP
ajmpe-878	36	14	the	the	DET
ajmpe-878	36	15	body	body	NOUN
ajmpe-878	36	16	(	(	PUNCT
ajmpe-878	36	17	centers	center	NOUN
ajmpe-878	36	18	for	for	ADP
ajmpe-878	36	19	disease	disease	NOUN
ajmpe-878	36	20	control	control	NOUN
ajmpe-878	36	21	and	and	CCONJ
ajmpe-878	36	22	prevention	prevention	NOUN
ajmpe-878	36	23	,	,	PUNCT
ajmpe-878	36	24	2022	2022	NUM
ajmpe-878	36	25	)	)	PUNCT
ajmpe-878	36	26	.	.	PUNCT
ajmpe-878	37	1	tb	tb	X
ajmpe-878	37	2	can	can	AUX
ajmpe-878	37	3	present	present	VERB
ajmpe-878	37	4	in	in	ADP
ajmpe-878	37	5	two	two	NUM
ajmpe-878	37	6	main	main	ADJ
ajmpe-878	37	7	forms	form	NOUN
ajmpe-878	37	8	:	:	PUNCT
ajmpe-878	37	9	latent	latent	NOUN
ajmpe-878	37	10	tb	tb	ADP
ajmpe-878	37	11	infection	infection	NOUN
ajmpe-878	37	12	and	and	CCONJ
ajmpe-878	37	13	active	active	ADJ
ajmpe-878	37	14	tb	tb	ADP
ajmpe-878	37	15	disease	disease	NOUN
ajmpe-878	37	16	.	.	PUNCT
ajmpe-878	38	1	latent	latent	NOUN
ajmpe-878	38	2	tb	tb	ADP
ajmpe-878	38	3	infection	infection	NOUN
ajmpe-878	38	4	occurs	occur	VERB
ajmpe-878	38	5	when	when	SCONJ
ajmpe-878	38	6	a	a	DET
ajmpe-878	38	7	person	person	NOUN
ajmpe-878	38	8	has	have	AUX
ajmpe-878	38	9	been	be	AUX
ajmpe-878	38	10	infected	infect	VERB
ajmpe-878	38	11	with	with	ADP
ajmpe-878	38	12	the	the	DET
ajmpe-878	38	13	tb	tb	NOUN
ajmpe-878	38	14	bacteria	bacteria	NOUN
ajmpe-878	38	15	but	but	CCONJ
ajmpe-878	38	16	does	do	AUX
ajmpe-878	38	17	not	not	PART
ajmpe-878	38	18	yet	yet	ADV
ajmpe-878	38	19	have	have	VERB
ajmpe-878	38	20	active	active	ADJ
ajmpe-878	38	21	disease	disease	NOUN
ajmpe-878	38	22	or	or	CCONJ
ajmpe-878	38	23	symptoms	symptom	NOUN
ajmpe-878	38	24	.	.	PUNCT
ajmpe-878	39	1	in	in	ADP
ajmpe-878	39	2	this	this	DET
ajmpe-878	39	3	case	case	NOUN
ajmpe-878	39	4	,	,	PUNCT
ajmpe-878	39	5	the	the	DET
ajmpe-878	39	6	bacteria	bacteria	NOUN
ajmpe-878	39	7	are	be	AUX
ajmpe-878	39	8	dormant	dormant	ADJ
ajmpe-878	39	9	and	and	CCONJ
ajmpe-878	39	10	can	can	AUX
ajmpe-878	39	11	not	not	PART
ajmpe-878	39	12	be	be	AUX
ajmpe-878	39	13	spread	spread	VERB
ajmpe-878	39	14	to	to	ADP
ajmpe-878	39	15	others	other	NOUN
ajmpe-878	39	16	.	.	PUNCT
ajmpe-878	40	1	however	however	ADV
ajmpe-878	40	2	,	,	PUNCT
ajmpe-878	40	3	people	people	NOUN
ajmpe-878	40	4	with	with	ADP
ajmpe-878	40	5	latent	latent	NOUN
ajmpe-878	40	6	tb	tb	ADP
ajmpe-878	40	7	infection	infection	NOUN
ajmpe-878	40	8	are	be	AUX
ajmpe-878	40	9	at	at	ADP
ajmpe-878	40	10	risk	risk	NOUN
ajmpe-878	40	11	of	of	ADP
ajmpe-878	40	12	developing	develop	VERB
ajmpe-878	40	13	active	active	ADJ
ajmpe-878	40	14	tb	tb	ADP
ajmpe-878	40	15	disease	disease	NOUN
ajmpe-878	40	16	if	if	SCONJ
ajmpe-878	40	17	their	their	PRON
ajmpe-878	40	18	immune	immune	ADJ
ajmpe-878	40	19	system	system	NOUN
ajmpe-878	40	20	becomes	becomes	AUX
ajmpe-878	40	21	weakened	weaken	VERB
ajmpe-878	40	22	(	(	PUNCT
ajmpe-878	40	23	centers	center	NOUN
ajmpe-878	40	24	for	for	ADP
ajmpe-878	40	25	disease	disease	NOUN
ajmpe-878	40	26	control	control	NOUN
ajmpe-878	40	27	and	and	CCONJ
ajmpe-878	40	28	2	2	NUM
ajmpe-878	40	29	med	med	ADJ
ajmpe-878	40	30	.	.	PUNCT
ajmpe-878	41	1	case	case	NOUN
ajmpe-878	41	2	stud	stud	NOUN
ajmpe-878	41	3	.	.	PUNCT
ajmpe-878	42	1	prevention	prevention	NOUN
ajmpe-878	42	2	,	,	PUNCT
ajmpe-878	42	3	2022	2022	NUM
ajmpe-878	42	4	)	)	PUNCT
ajmpe-878	42	5	.	.	PUNCT
ajmpe-878	43	1	covid-19	covid-19	PROPN
ajmpe-878	43	2	infection	infection	NOUN
ajmpe-878	43	3	can	can	AUX
ajmpe-878	43	4	increase	increase	VERB
ajmpe-878	43	5	the	the	DET
ajmpe-878	43	6	risk	risk	NOUN
ajmpe-878	43	7	of	of	ADP
ajmpe-878	43	8	tb	tb	ADP
ajmpe-878	43	9	reactivation	reactivation	NOUN
ajmpe-878	43	10	due	due	ADP
ajmpe-878	43	11	to	to	ADP
ajmpe-878	43	12	a	a	DET
ajmpe-878	43	13	combination	combination	NOUN
ajmpe-878	43	14	of	of	ADP
ajmpe-878	43	15	factors	factor	NOUN
ajmpe-878	43	16	.	.	PUNCT
ajmpe-878	44	1	these	these	DET
ajmpe-878	44	2	factors	factor	NOUN
ajmpe-878	44	3	include	include	VERB
ajmpe-878	44	4	immune	immune	ADJ
ajmpe-878	44	5	system	system	NOUN
ajmpe-878	44	6	suppression	suppression	NOUN
ajmpe-878	44	7	,	,	PUNCT
ajmpe-878	44	8	as	as	ADV
ajmpe-878	44	9	well	well	ADV
ajmpe-878	44	10	as	as	ADP
ajmpe-878	44	11	disruptions	disruption	NOUN
ajmpe-878	44	12	to	to	ADP
ajmpe-878	44	13	tb	tb	ADP
ajmpe-878	44	14	diagnosis	diagnosis	NOUN
ajmpe-878	44	15	,	,	PUNCT
ajmpe-878	44	16	treatment	treatment	NOUN
ajmpe-878	44	17	,	,	PUNCT
ajmpe-878	44	18	and	and	CCONJ
ajmpe-878	44	19	prevention	prevention	NOUN
ajmpe-878	44	20	services	service	NOUN
ajmpe-878	44	21	(	(	PUNCT
ajmpe-878	44	22	world	world	NOUN
ajmpe-878	44	23	health	health	NOUN
ajmpe-878	44	24	organization	organization	NOUN
ajmpe-878	44	25	,	,	PUNCT
ajmpe-878	44	26	2022b	2022b	NUM
ajmpe-878	44	27	)	)	PUNCT
ajmpe-878	44	28	.	.	PUNCT
ajmpe-878	45	1	tuberculous	tuberculous	ADJ
ajmpe-878	45	2	meningitis	meningitis	NOUN
ajmpe-878	45	3	(	(	PUNCT
ajmpe-878	45	4	tbm	tbm	NOUN
ajmpe-878	45	5	)	)	PUNCT
ajmpe-878	45	6	is	be	AUX
ajmpe-878	45	7	one	one	NUM
ajmpe-878	45	8	of	of	ADP
ajmpe-878	45	9	the	the	DET
ajmpe-878	45	10	most	most	ADV
ajmpe-878	45	11	severe	severe	ADJ
ajmpe-878	45	12	manifestations	manifestation	NOUN
ajmpe-878	45	13	of	of	ADP
ajmpe-878	45	14	extrapulmonary	extrapulmonary	NOUN
ajmpe-878	45	15	tb	tb	PROPN
ajmpe-878	45	16	.	.	PUNCT
ajmpe-878	45	17	cns	cns	PROPN
ajmpe-878	45	18	-	-	PUNCT
ajmpe-878	45	19	tb	tb	NOUN
ajmpe-878	45	20	represented	represent	VERB
ajmpe-878	45	21	the	the	DET
ajmpe-878	45	22	13.91	13.91	NUM
ajmpe-878	45	23	%	%	NOUN
ajmpe-878	45	24	of	of	ADP
ajmpe-878	45	25	all	all	DET
ajmpe-878	45	26	cases	case	NOUN
ajmpe-878	45	27	of	of	ADP
ajmpe-878	45	28	meningitis	meningitis	NOUN
ajmpe-878	45	29	and	and	CCONJ
ajmpe-878	45	30	4.55	4.55	NUM
ajmpe-878	45	31	%	%	NOUN
ajmpe-878	45	32	of	of	ADP
ajmpe-878	45	33	all	all	DET
ajmpe-878	45	34	cases	case	NOUN
ajmpe-878	45	35	of	of	ADP
ajmpe-878	45	36	tb	tb	X
ajmpe-878	45	37	(	(	PUNCT
ajmpe-878	45	38	navarro	navarro	PROPN
ajmpe-878	45	39	-	-	PUNCT
ajmpe-878	45	40	flores	flores	PROPN
ajmpe-878	45	41	et	et	PROPN
ajmpe-878	45	42	al	al	PROPN
ajmpe-878	45	43	.	.	PROPN
ajmpe-878	45	44	,	,	PUNCT
ajmpe-878	45	45	2022	2022	NUM
ajmpe-878	45	46	)	)	PUNCT
ajmpe-878	45	47	.	.	PUNCT
ajmpe-878	46	1	the	the	DET
ajmpe-878	46	2	pathophysiology	pathophysiology	NOUN
ajmpe-878	46	3	is	be	AUX
ajmpe-878	46	4	primarily	primarily	ADV
ajmpe-878	46	5	driven	drive	VERB
ajmpe-878	46	6	by	by	ADP
ajmpe-878	46	7	three	three	NUM
ajmpe-878	46	8	components	component	NOUN
ajmpe-878	46	9	,	,	PUNCT
ajmpe-878	46	10	which	which	PRON
ajmpe-878	46	11	also	also	ADV
ajmpe-878	46	12	explain	explain	VERB
ajmpe-878	46	13	the	the	DET
ajmpe-878	46	14	clinical	clinical	ADJ
ajmpe-878	46	15	symptoms	symptom	NOUN
ajmpe-878	46	16	(	(	PUNCT
ajmpe-878	46	17	rich	rich	ADJ
ajmpe-878	46	18	and	and	CCONJ
ajmpe-878	46	19	mccordock	mccordock	ADJ
ajmpe-878	46	20	,	,	PUNCT
ajmpe-878	46	21	1933	1933	NUM
ajmpe-878	46	22	;	;	PUNCT
ajmpe-878	46	23	dastur	dastur	PROPN
ajmpe-878	46	24	et	et	PROPN
ajmpe-878	46	25	al	al	PROPN
ajmpe-878	46	26	.	.	PROPN
ajmpe-878	46	27	,	,	PUNCT
ajmpe-878	46	28	1995	1995	NUM
ajmpe-878	46	29	)	)	PUNCT
ajmpe-878	46	30	.	.	PUNCT
ajmpe-878	47	1	thick	thick	ADJ
ajmpe-878	47	2	gelatinous	gelatinous	ADJ
ajmpe-878	47	3	exudate	exudate	NOUN
ajmpe-878	47	4	,	,	PUNCT
ajmpe-878	47	5	which	which	PRON
ajmpe-878	47	6	is	be	AUX
ajmpe-878	47	7	especially	especially	ADV
ajmpe-878	47	8	apparent	apparent	ADJ
ajmpe-878	47	9	at	at	ADP
ajmpe-878	47	10	the	the	DET
ajmpe-878	47	11	basal	basal	ADJ
ajmpe-878	47	12	region	region	NOUN
ajmpe-878	47	13	of	of	ADP
ajmpe-878	47	14	the	the	DET
ajmpe-878	47	15	brain	brain	NOUN
ajmpe-878	47	16	,	,	PUNCT
ajmpe-878	47	17	eventually	eventually	ADV
ajmpe-878	47	18	produces	produce	VERB
ajmpe-878	47	19	a	a	DET
ajmpe-878	47	20	fibrous	fibrous	ADJ
ajmpe-878	47	21	mass	mass	NOUN
ajmpe-878	47	22	that	that	PRON
ajmpe-878	47	23	encases	encase	VERB
ajmpe-878	47	24	nearby	nearby	ADJ
ajmpe-878	47	25	structures	structure	NOUN
ajmpe-878	47	26	.	.	PUNCT
ajmpe-878	48	1	as	as	ADP
ajmpe-878	48	2	a	a	DET
ajmpe-878	48	3	result	result	NOUN
ajmpe-878	48	4	,	,	PUNCT
ajmpe-878	48	5	periventricular	periventricular	ADJ
ajmpe-878	48	6	infarcts	infarct	NOUN
ajmpe-878	48	7	and	and	CCONJ
ajmpe-878	48	8	cranial	cranial	ADJ
ajmpe-878	48	9	nerve	nerve	NOUN
ajmpe-878	48	10	palsies	palsy	NOUN
ajmpe-878	48	11	are	be	AUX
ajmpe-878	48	12	developed	develop	VERB
ajmpe-878	48	13	.	.	PUNCT
ajmpe-878	49	1	spasm	spasm	NOUN
ajmpe-878	49	2	,	,	PUNCT
ajmpe-878	49	3	constriction	constriction	NOUN
ajmpe-878	49	4	,	,	PUNCT
ajmpe-878	49	5	thrombosis	thrombosis	NOUN
ajmpe-878	49	6	,	,	PUNCT
ajmpe-878	49	7	and	and	CCONJ
ajmpe-878	49	8	occlusion	occlusion	NOUN
ajmpe-878	49	9	of	of	ADP
ajmpe-878	49	10	intracerebral	intracerebral	ADJ
ajmpe-878	49	11	arteries	artery	NOUN
ajmpe-878	49	12	are	be	AUX
ajmpe-878	49	13	all	all	PRON
ajmpe-878	49	14	possible	possible	ADJ
ajmpe-878	49	15	effects	effect	NOUN
ajmpe-878	49	16	of	of	ADP
ajmpe-878	49	17	tuberculous	tuberculous	ADJ
ajmpe-878	49	18	vasculitis	vasculitis	NOUN
ajmpe-878	49	19	and	and	CCONJ
ajmpe-878	49	20	the	the	DET
ajmpe-878	49	21	concomitant	concomitant	ADJ
ajmpe-878	49	22	inflammatory	inflammatory	ADJ
ajmpe-878	49	23	vascular	vascular	ADJ
ajmpe-878	49	24	changes	change	NOUN
ajmpe-878	49	25	(	(	PUNCT
ajmpe-878	49	26	chan	chan	X
ajmpe-878	49	27	et	et	PROPN
ajmpe-878	49	28	al	al	PROPN
ajmpe-878	49	29	.	.	PROPN
ajmpe-878	49	30	,	,	PUNCT
ajmpe-878	49	31	2005	2005	NUM
ajmpe-878	49	32	)	)	PUNCT
ajmpe-878	49	33	.	.	PUNCT
ajmpe-878	50	1	the	the	DET
ajmpe-878	50	2	intracranial	intracranial	ADJ
ajmpe-878	50	3	vasculitis	vasculitis	PROPN
ajmpe-878	50	4	is	be	AUX
ajmpe-878	50	5	expected	expect	VERB
ajmpe-878	50	6	to	to	PART
ajmpe-878	50	7	have	have	VERB
ajmpe-878	50	8	a	a	DET
ajmpe-878	50	9	major	major	ADJ
ajmpe-878	50	10	impact	impact	NOUN
ajmpe-878	50	11	on	on	ADP
ajmpe-878	50	12	the	the	DET
ajmpe-878	50	13	remaining	remain	VERB
ajmpe-878	50	14	neurologic	neurologic	ADJ
ajmpe-878	50	15	deficits	deficit	NOUN
ajmpe-878	50	16	(	(	PUNCT
ajmpe-878	50	17	poltera	poltera	NOUN
ajmpe-878	50	18	,	,	PUNCT
ajmpe-878	50	19	1977	1977	NUM
ajmpe-878	50	20	)	)	PUNCT
ajmpe-878	50	21	.	.	PUNCT
ajmpe-878	51	1	clinical	clinical	ADJ
ajmpe-878	51	2	approach	approach	NOUN
ajmpe-878	51	3	and	and	CCONJ
ajmpe-878	51	4	diagnostic	diagnostic	ADJ
ajmpe-878	51	5	tools	tool	NOUN
ajmpe-878	51	6	,	,	PUNCT
ajmpe-878	51	7	including	include	VERB
ajmpe-878	51	8	csf	csf	ADJ
ajmpe-878	51	9	analysis	analysis	NOUN
ajmpe-878	51	10	and	and	CCONJ
ajmpe-878	51	11	radiographic	radiographic	ADJ
ajmpe-878	51	12	imaging	imaging	NOUN
ajmpe-878	51	13	,	,	PUNCT
ajmpe-878	51	14	are	be	AUX
ajmpe-878	51	15	equally	equally	ADV
ajmpe-878	51	16	important	important	ADJ
ajmpe-878	51	17	to	to	PART
ajmpe-878	51	18	diagnose	diagnose	VERB
ajmpe-878	51	19	tb	tb	ADP
ajmpe-878	51	20	meningitis	meningitis	NOUN
ajmpe-878	51	21	(	(	PUNCT
ajmpe-878	51	22	lewinsohn	lewinsohn	PROPN
ajmpe-878	51	23	et	et	PROPN
ajmpe-878	51	24	al	al	PROPN
ajmpe-878	51	25	.	.	PROPN
ajmpe-878	51	26	,	,	PUNCT
ajmpe-878	51	27	2017	2017	NUM
ajmpe-878	51	28	)	)	PUNCT
ajmpe-878	51	29	.	.	PUNCT
ajmpe-878	52	1	the	the	DET
ajmpe-878	52	2	treatment	treatment	NOUN
ajmpe-878	52	3	for	for	ADP
ajmpe-878	52	4	tuberculous	tuberculous	ADJ
ajmpe-878	52	5	meningitis	meningitis	NOUN
ajmpe-878	52	6	is	be	AUX
ajmpe-878	52	7	very	very	ADV
ajmpe-878	52	8	complex	complex	ADJ
ajmpe-878	52	9	.	.	PUNCT
ajmpe-878	53	1	commonly	commonly	ADV
ajmpe-878	53	2	,	,	PUNCT
ajmpe-878	53	3	the	the	DET
ajmpe-878	53	4	combination	combination	NOUN
ajmpe-878	53	5	of	of	ADP
ajmpe-878	53	6	isoniazid	isoniazid	NOUN
ajmpe-878	53	7	,	,	PUNCT
ajmpe-878	53	8	rifampin	rifampin	NOUN
ajmpe-878	53	9	,	,	PUNCT
ajmpe-878	53	10	pyrazinamide	pyrazinamide	VERB
ajmpe-878	53	11	and	and	CCONJ
ajmpe-878	53	12	ethambutol	ethambutol	ADV
ajmpe-878	53	13	/	/	SYM
ajmpe-878	53	14	streptomycin/	streptomycin/	NUM
ajmpe-878	53	15	fluoroquinolone	fluoroquinolone	NOUN
ajmpe-878	53	16	is	be	AUX
ajmpe-878	53	17	given	give	VERB
ajmpe-878	53	18	for	for	ADP
ajmpe-878	53	19	an	an	DET
ajmpe-878	53	20	extended	extended	ADJ
ajmpe-878	53	21	period	period	NOUN
ajmpe-878	53	22	of	of	ADP
ajmpe-878	53	23	time	time	NOUN
ajmpe-878	53	24	.	.	PUNCT
ajmpe-878	54	1	however	however	ADV
ajmpe-878	54	2	,	,	PUNCT
ajmpe-878	54	3	sometimes	sometimes	ADV
ajmpe-878	54	4	drug	drug	NOUN
ajmpe-878	54	5	resistance	resistance	NOUN
ajmpe-878	54	6	is	be	AUX
ajmpe-878	54	7	found	find	VERB
ajmpe-878	54	8	which	which	PRON
ajmpe-878	54	9	leads	lead	VERB
ajmpe-878	54	10	to	to	ADP
ajmpe-878	54	11	adjustments	adjustment	NOUN
ajmpe-878	54	12	in	in	ADP
ajmpe-878	54	13	treatment	treatment	NOUN
ajmpe-878	54	14	(	(	PUNCT
ajmpe-878	54	15	donald	donald	PROPN
ajmpe-878	54	16	,	,	PUNCT
ajmpe-878	54	17	2010	2010	NUM
ajmpe-878	54	18	;	;	PUNCT
ajmpe-878	54	19	world	world	NOUN
ajmpe-878	54	20	health	health	NOUN
ajmpe-878	54	21	organization	organization	NOUN
ajmpe-878	54	22	,	,	PUNCT
ajmpe-878	54	23	2017	2017	NUM
ajmpe-878	54	24	)	)	PUNCT
ajmpe-878	54	25	.	.	PUNCT
ajmpe-878	55	1	this	this	DET
ajmpe-878	55	2	case	case	NOUN
ajmpe-878	55	3	describes	describe	VERB
ajmpe-878	55	4	the	the	DET
ajmpe-878	55	5	development	development	NOUN
ajmpe-878	55	6	of	of	ADP
ajmpe-878	55	7	tuberculous	tuberculous	ADJ
ajmpe-878	55	8	meningitis	meningitis	NOUN
ajmpe-878	55	9	in	in	ADP
ajmpe-878	55	10	a	a	DET
ajmpe-878	55	11	patient	patient	NOUN
ajmpe-878	55	12	with	with	ADP
ajmpe-878	55	13	covid-19	covid-19	PROPN
ajmpe-878	55	14	.	.	PUNCT
ajmpe-878	55	15	case	case	NOUN
ajmpe-878	55	16	presentation	presentation	NOUN
ajmpe-878	55	17	39	39	NUM
ajmpe-878	55	18	-	-	PUNCT
ajmpe-878	55	19	year	year	NOUN
ajmpe-878	55	20	-	-	PUNCT
ajmpe-878	55	21	old	old	ADJ
ajmpe-878	55	22	male	male	NOUN
ajmpe-878	55	23	presented	present	VERB
ajmpe-878	55	24	to	to	ADP
ajmpe-878	55	25	the	the	DET
ajmpe-878	55	26	emergency	emergency	NOUN
ajmpe-878	55	27	department	department	NOUN
ajmpe-878	55	28	on	on	ADP
ajmpe-878	55	29	june	june	PROPN
ajmpe-878	55	30	4	4	NUM
ajmpe-878	55	31	,	,	PUNCT
ajmpe-878	55	32	2022	2022	NUM
ajmpe-878	55	33	,	,	PUNCT
ajmpe-878	55	34	with	with	ADP
ajmpe-878	55	35	fatigue	fatigue	NOUN
ajmpe-878	55	36	,	,	PUNCT
ajmpe-878	55	37	fever	fever	NOUN
ajmpe-878	55	38	,	,	PUNCT
ajmpe-878	55	39	shortness	shortness	NOUN
ajmpe-878	55	40	of	of	ADP
ajmpe-878	55	41	breath	breath	NOUN
ajmpe-878	55	42	,	,	PUNCT
ajmpe-878	55	43	nausea	nausea	NOUN
ajmpe-878	55	44	,	,	PUNCT
ajmpe-878	55	45	and	and	CCONJ
ajmpe-878	55	46	vomiting	vomiting	NOUN
ajmpe-878	55	47	.	.	PUNCT
ajmpe-878	56	1	he	he	PRON
ajmpe-878	56	2	tested	test	VERB
ajmpe-878	56	3	positive	positive	ADJ
ajmpe-878	56	4	for	for	ADP
ajmpe-878	56	5	covid-19	covid-19	PROPN
ajmpe-878	56	6	.	.	PUNCT
ajmpe-878	57	1	a	a	DET
ajmpe-878	57	2	cardiopulmonary	cardiopulmonary	ADJ
ajmpe-878	57	3	examination	examination	NOUN
ajmpe-878	57	4	showed	show	VERB
ajmpe-878	57	5	clear	clear	ADJ
ajmpe-878	57	6	lung	lung	NOUN
ajmpe-878	57	7	fields	field	NOUN
ajmpe-878	57	8	and	and	CCONJ
ajmpe-878	57	9	normal	normal	ADJ
ajmpe-878	57	10	heart	heart	NOUN
ajmpe-878	57	11	sounds	sound	VERB
ajmpe-878	57	12	.	.	PUNCT
ajmpe-878	58	1	neurological	neurological	ADJ
ajmpe-878	58	2	assessment	assessment	NOUN
ajmpe-878	58	3	showed	show	VERB
ajmpe-878	58	4	signs	sign	NOUN
ajmpe-878	58	5	of	of	ADP
ajmpe-878	58	6	ataxia	ataxia	NOUN
ajmpe-878	58	7	,	,	PUNCT
ajmpe-878	58	8	vertigo	vertigo	NOUN
ajmpe-878	58	9	,	,	PUNCT
ajmpe-878	58	10	and	and	CCONJ
ajmpe-878	58	11	horizontal	horizontal	ADJ
ajmpe-878	58	12	nystagmus	nystagmus	NOUN
ajmpe-878	58	13	;	;	PUNCT
ajmpe-878	58	14	however	however	ADV
ajmpe-878	58	15	,	,	PUNCT
ajmpe-878	58	16	a	a	DET
ajmpe-878	58	17	head	head	NOUN
ajmpe-878	58	18	ct	ct	PROPN
ajmpe-878	58	19	scan	scan	NOUN
ajmpe-878	58	20	has	have	AUX
ajmpe-878	58	21	not	not	PART
ajmpe-878	58	22	shown	show	VERB
ajmpe-878	58	23	any	any	DET
ajmpe-878	58	24	pathological	pathological	ADJ
ajmpe-878	58	25	features	feature	NOUN
ajmpe-878	58	26	.	.	PUNCT
ajmpe-878	59	1	two	two	NUM
ajmpe-878	59	2	days	day	NOUN
ajmpe-878	59	3	later	later	ADV
ajmpe-878	59	4	,	,	PUNCT
ajmpe-878	59	5	the	the	DET
ajmpe-878	59	6	patient	patient	NOUN
ajmpe-878	59	7	developed	develop	VERB
ajmpe-878	59	8	new	new	ADJ
ajmpe-878	59	9	clinical	clinical	ADJ
ajmpe-878	59	10	signs	sign	NOUN
ajmpe-878	59	11	,	,	PUNCT
ajmpe-878	59	12	including	include	VERB
ajmpe-878	59	13	facial	facial	ADJ
ajmpe-878	59	14	asymmetry	asymmetry	NOUN
ajmpe-878	59	15	with	with	ADP
ajmpe-878	59	16	loss	loss	NOUN
ajmpe-878	59	17	of	of	ADP
ajmpe-878	59	18	the	the	DET
ajmpe-878	59	19	left	left	ADJ
ajmpe-878	59	20	nasolabial	nasolabial	ADJ
ajmpe-878	59	21	fold	fold	NOUN
ajmpe-878	59	22	,	,	PUNCT
ajmpe-878	59	23	right	right	ADJ
ajmpe-878	59	24	-	-	PUNCT
ajmpe-878	59	25	sided	side	VERB
ajmpe-878	59	26	ptosis	ptosis	NOUN
ajmpe-878	59	27	,	,	PUNCT
ajmpe-878	59	28	spontaneous	spontaneous	ADJ
ajmpe-878	59	29	rotatory	rotatory	ADJ
ajmpe-878	59	30	nystagmus	nystagmus	NOUN
ajmpe-878	59	31	,	,	PUNCT
ajmpe-878	59	32	dysphagia	dysphagia	NOUN
ajmpe-878	59	33	,	,	PUNCT
ajmpe-878	59	34	dysarthria	dysarthria	NOUN
ajmpe-878	59	35	,	,	PUNCT
ajmpe-878	59	36	and	and	CCONJ
ajmpe-878	59	37	trouble	trouble	NOUN
ajmpe-878	59	38	coordinating	coordinate	VERB
ajmpe-878	59	39	.	.	PUNCT
ajmpe-878	60	1	jaw	jaw	PROPN
ajmpe-878	60	2	jerk	jerk	PROPN
ajmpe-878	60	3	and	and	CCONJ
ajmpe-878	60	4	gag	gag	NOUN
ajmpe-878	60	5	reflexes	reflex	NOUN
ajmpe-878	60	6	were	be	AUX
ajmpe-878	60	7	both	both	PRON
ajmpe-878	60	8	diminished	diminish	VERB
ajmpe-878	60	9	.	.	PUNCT
ajmpe-878	61	1	reduced	reduce	VERB
ajmpe-878	61	2	deep	deep	ADJ
ajmpe-878	61	3	tendon	tendon	NOUN
ajmpe-878	61	4	reflexes	reflex	NOUN
ajmpe-878	61	5	were	be	AUX
ajmpe-878	61	6	present	present	ADJ
ajmpe-878	61	7	in	in	ADP
ajmpe-878	61	8	all	all	DET
ajmpe-878	61	9	extremities	extremity	NOUN
ajmpe-878	61	10	,	,	PUNCT
ajmpe-878	61	11	more	more	ADV
ajmpe-878	61	12	so	so	ADV
ajmpe-878	61	13	on	on	ADP
ajmpe-878	61	14	the	the	DET
ajmpe-878	61	15	left	left	NOUN
ajmpe-878	61	16	.	.	PUNCT
ajmpe-878	62	1	he	he	PRON
ajmpe-878	62	2	also	also	ADV
ajmpe-878	62	3	suffered	suffer	VERB
ajmpe-878	62	4	from	from	ADP
ajmpe-878	62	5	neck	neck	NOUN
ajmpe-878	62	6	rigidity	rigidity	NOUN
ajmpe-878	62	7	.	.	PUNCT
ajmpe-878	63	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-878	63	2	american	american	PROPN
ajmpe-878	63	3	journal	journal	PROPN
ajmpe-878	63	4	of	of	ADP
ajmpe-878	63	5	medical	medical	ADJ
ajmpe-878	63	6	and	and	CCONJ
ajmpe-878	63	7	physical	physical	ADJ
ajmpe-878	63	8	education	education	NOUN
ajmpe-878	63	9	vol.9	vol.9	PROPN
ajmpe-878	63	10	,	,	PUNCT
ajmpe-878	63	11	issue	issue	NOUN
ajmpe-878	63	12	1	1	NUM
ajmpe-878	63	13	;	;	PUNCT
ajmpe-878	63	14	january	january	PROPN
ajmpe-878	63	15	-	-	PUNCT
ajmpe-878	63	16	february	february	PROPN
ajmpe-878	63	17	2024	2024	NUM
ajmpe-878	63	18	;	;	PUNCT
ajmpe-878	63	19	issn	issn	PROPN
ajmpe-878	63	20	:	:	PUNCT
ajmpe-878	63	21	2994	2994	NUM
ajmpe-878	63	22	-	-	SYM
ajmpe-878	63	23	0524	0524	NUM
ajmpe-878	63	24	impact	impact	NOUN
ajmpe-878	63	25	factor	factor	NOUN
ajmpe-878	63	26	:	:	PUNCT
ajmpe-878	63	27	6.14	6.14	NUM
ajmpe-878	63	28	1252	1252	NUM
ajmpe-878	63	29	columbia	columbia	PROPN
ajmpe-878	63	30	rd	rd	PROPN
ajmpe-878	63	31	nw	nw	PROPN
ajmpe-878	63	32	,	,	PUNCT
ajmpe-878	63	33	washington	washington	PROPN
ajmpe-878	63	34	dc	dc	PROPN
ajmpe-878	63	35	,	,	PUNCT
ajmpe-878	63	36	united	united	PROPN
ajmpe-878	63	37	states	states	PROPN
ajmpe-878	63	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	63	39	;	;	PUNCT
ajmpe-878	63	40	mail	mail	NOUN
ajmpe-878	63	41	:	:	PUNCT
ajmpe-878	63	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	64	1	3	3	NUM
ajmpe-878	65	1	|	|	ADV
ajmpe-878	65	2	a	a	DET
ajmpe-878	65	3	m	m	NOUN
ajmpe-878	65	4	e	e	NOUN
ajmpe-878	65	5	r	r	NOUN
ajmpe-878	66	1	i	i	NOUN
ajmpe-878	66	2	c	c	VERB
ajmpe-878	66	3	a	a	DET
ajmpe-878	66	4	n	n	NOUN
ajmpe-878	67	1	j	j	NOUN
ajmpe-878	67	2	o	o	X
ajmpe-878	67	3	u	u	NOUN
ajmpe-878	67	4	r	r	NOUN
ajmpe-878	67	5	n	n	NOUN
ajmpe-878	67	6	a	a	DET
ajmpe-878	67	7	l	l	NOUN
ajmpe-878	67	8	o	o	X
ajmpe-878	68	1	f	f	X
ajmpe-878	68	2	m	m	NOUN
ajmpe-878	68	3	e	e	NOUN
ajmpe-878	69	1	d	d	NOUN
ajmpe-878	69	2	i	i	PRON
ajmpe-878	69	3	c	c	VERB
ajmpe-878	69	4	a	a	DET
ajmpe-878	69	5	l	l	NOUN
ajmpe-878	69	6	a	a	X
ajmpe-878	69	7	n	n	NOUN
ajmpe-878	70	1	d	d	NOUN
ajmpe-878	70	2	p	p	NOUN
ajmpe-878	70	3	h	h	NOUN
ajmpe-878	70	4	y	y	NOUN
ajmpe-878	70	5	s	s	VERB
ajmpe-878	71	1	i	i	INTJ
ajmpe-878	71	2	c	c	VERB
ajmpe-878	71	3	a	a	DET
ajmpe-878	71	4	l	l	NOUN
ajmpe-878	71	5	e	e	NOUN
ajmpe-878	71	6	d	d	X
ajmpe-878	71	7	u	u	X
ajmpe-878	71	8	c	c	PROPN
ajmpe-878	72	1	a	a	DET
ajmpe-878	72	2	t	t	NOUN
ajmpe-878	73	1	i	i	PRON
ajmpe-878	73	2	o	o	VERB
ajmpe-878	74	1	n	n	CCONJ
ajmpe-878	74	2	|	|	ADV
ajmpe-878	74	3	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	74	4	a	a	DET
ajmpe-878	74	5	head	head	NOUN
ajmpe-878	74	6	mri	mri	NOUN
ajmpe-878	74	7	revealed	reveal	VERB
ajmpe-878	74	8	hyperintensity	hyperintensity	NOUN
ajmpe-878	74	9	in	in	ADP
ajmpe-878	74	10	the	the	DET
ajmpe-878	74	11	brainstem	brainstem	NOUN
ajmpe-878	74	12	and	and	CCONJ
ajmpe-878	74	13	left	leave	VERB
ajmpe-878	74	14	cerebellum	cerebellum	NOUN
ajmpe-878	74	15	(	(	PUNCT
ajmpe-878	74	16	figures	figure	NOUN
ajmpe-878	74	17	1	1	NUM
ajmpe-878	74	18	and	and	CCONJ
ajmpe-878	74	19	2	2	NUM
ajmpe-878	74	20	)	)	PUNCT
ajmpe-878	74	21	.	.	PUNCT
ajmpe-878	75	1	csf	csf	ADJ
ajmpe-878	75	2	analysis	analysis	NOUN
ajmpe-878	75	3	revealed	reveal	VERB
ajmpe-878	75	4	lymphocytosis	lymphocytosis	NOUN
ajmpe-878	75	5	,	,	PUNCT
ajmpe-878	75	6	decreased	decrease	VERB
ajmpe-878	75	7	glucose	glucose	NOUN
ajmpe-878	75	8	,	,	PUNCT
ajmpe-878	75	9	and	and	CCONJ
ajmpe-878	75	10	elevated	elevated	ADJ
ajmpe-878	75	11	protein	protein	NOUN
ajmpe-878	75	12	.	.	PUNCT
ajmpe-878	76	1	adenosine	adenosine	ADJ
ajmpe-878	76	2	deaminase	deaminase	NOUN
ajmpe-878	76	3	levels	level	NOUN
ajmpe-878	76	4	and	and	CCONJ
ajmpe-878	76	5	csf	csf	ADJ
ajmpe-878	76	6	pcr	pcr	NOUN
ajmpe-878	76	7	for	for	ADP
ajmpe-878	76	8	tuberculosis	tuberculosis	NOUN
ajmpe-878	76	9	were	be	AUX
ajmpe-878	76	10	both	both	ADV
ajmpe-878	76	11	positive	positive	ADJ
ajmpe-878	76	12	as	as	ADV
ajmpe-878	76	13	well	well	ADV
ajmpe-878	76	14	.	.	PUNCT
ajmpe-878	77	1	following	follow	VERB
ajmpe-878	77	2	the	the	DET
ajmpe-878	77	3	lumber	lumber	NOUN
ajmpe-878	77	4	puncture	puncture	NOUN
ajmpe-878	77	5	,	,	PUNCT
ajmpe-878	77	6	treatment	treatment	NOUN
ajmpe-878	77	7	with	with	ADP
ajmpe-878	77	8	dexamethasone	dexamethasone	NOUN
ajmpe-878	77	9	,	,	PUNCT
ajmpe-878	77	10	vancomycin	vancomycin	PROPN
ajmpe-878	77	11	,	,	PUNCT
ajmpe-878	77	12	and	and	CCONJ
ajmpe-878	77	13	ceftriaxone	ceftriaxone	PROPN
ajmpe-878	77	14	was	be	AUX
ajmpe-878	77	15	started	start	VERB
ajmpe-878	77	16	immediately	immediately	ADV
ajmpe-878	77	17	due	due	ADP
ajmpe-878	77	18	to	to	ADP
ajmpe-878	77	19	an	an	DET
ajmpe-878	77	20	increased	increase	VERB
ajmpe-878	77	21	suspicion	suspicion	NOUN
ajmpe-878	77	22	of	of	ADP
ajmpe-878	77	23	meningitis	meningitis	NOUN
ajmpe-878	77	24	.	.	PUNCT
ajmpe-878	78	1	after	after	SCONJ
ajmpe-878	78	2	the	the	DET
ajmpe-878	78	3	patient	patient	NOUN
ajmpe-878	78	4	's	's	PART
ajmpe-878	78	5	cerebrospinal	cerebrospinal	ADJ
ajmpe-878	78	6	fluid	fluid	NOUN
ajmpe-878	78	7	results	result	NOUN
ajmpe-878	78	8	confirmed	confirm	VERB
ajmpe-878	78	9	tb	tb	ADP
ajmpe-878	78	10	meningitis	meningitis	NOUN
ajmpe-878	78	11	,	,	PUNCT
ajmpe-878	78	12	the	the	DET
ajmpe-878	78	13	treatment	treatment	NOUN
ajmpe-878	78	14	regimen	regiman	NOUN
ajmpe-878	78	15	was	be	AUX
ajmpe-878	78	16	adjusted	adjust	VERB
ajmpe-878	78	17	to	to	ADP
ajmpe-878	78	18	streptomycin	streptomycin	PROPN
ajmpe-878	78	19	,	,	PUNCT
ajmpe-878	78	20	rifampicin	rifampicin	VERB
ajmpe-878	78	21	,	,	PUNCT
ajmpe-878	78	22	isoniazid	isoniazid	NOUN
ajmpe-878	78	23	,	,	PUNCT
ajmpe-878	78	24	pyrazinamide	pyrazinamide	NOUN
ajmpe-878	78	25	and	and	CCONJ
ajmpe-878	78	26	dexamethasone	dexamethasone	NOUN
ajmpe-878	78	27	.	.	PUNCT
ajmpe-878	79	1	the	the	DET
ajmpe-878	79	2	following	following	ADJ
ajmpe-878	79	3	day	day	NOUN
ajmpe-878	79	4	,	,	PUNCT
ajmpe-878	79	5	the	the	DET
ajmpe-878	79	6	patient	patient	NOUN
ajmpe-878	79	7	was	be	AUX
ajmpe-878	79	8	diagnosed	diagnose	VERB
ajmpe-878	79	9	with	with	ADP
ajmpe-878	79	10	purulent	purulent	ADJ
ajmpe-878	79	11	endobronchitis	endobronchitis	NOUN
ajmpe-878	79	12	based	base	VERB
ajmpe-878	79	13	on	on	ADP
ajmpe-878	79	14	an	an	DET
ajmpe-878	79	15	x	x	NOUN
ajmpe-878	79	16	-	-	NOUN
ajmpe-878	79	17	ray	ray	NOUN
ajmpe-878	79	18	and	and	CCONJ
ajmpe-878	79	19	bronchoalveolar	bronchoalveolar	ADJ
ajmpe-878	79	20	lavage	lavage	NOUN
ajmpe-878	79	21	.	.	PUNCT
ajmpe-878	80	1	soon	soon	ADV
ajmpe-878	80	2	after	after	ADV
ajmpe-878	80	3	,	,	PUNCT
ajmpe-878	80	4	he	he	PRON
ajmpe-878	80	5	developed	develop	VERB
ajmpe-878	80	6	a	a	DET
ajmpe-878	80	7	cytokine	cytokine	ADJ
ajmpe-878	80	8	storm	storm	NOUN
ajmpe-878	80	9	and	and	CCONJ
ajmpe-878	80	10	was	be	AUX
ajmpe-878	80	11	taken	take	VERB
ajmpe-878	80	12	to	to	ADP
ajmpe-878	80	13	the	the	DET
ajmpe-878	80	14	intensive	intensive	ADJ
ajmpe-878	80	15	care	care	NOUN
ajmpe-878	80	16	unit	unit	NOUN
ajmpe-878	80	17	,	,	PUNCT
ajmpe-878	80	18	where	where	SCONJ
ajmpe-878	80	19	he	he	PRON
ajmpe-878	80	20	was	be	AUX
ajmpe-878	80	21	intubated	intubate	VERB
ajmpe-878	80	22	,	,	PUNCT
ajmpe-878	80	23	sedated	sedated	ADJ
ajmpe-878	80	24	,	,	PUNCT
ajmpe-878	80	25	and	and	CCONJ
ajmpe-878	80	26	mechanically	mechanically	ADV
ajmpe-878	80	27	ventilated	ventilate	VERB
ajmpe-878	80	28	.	.	PUNCT
ajmpe-878	81	1	due	due	ADP
ajmpe-878	81	2	to	to	ADP
ajmpe-878	81	3	a	a	DET
ajmpe-878	81	4	protracted	protract	VERB
ajmpe-878	81	5	need	need	NOUN
ajmpe-878	81	6	for	for	ADP
ajmpe-878	81	7	breathing	breathing	NOUN
ajmpe-878	81	8	support	support	NOUN
ajmpe-878	81	9	,	,	PUNCT
ajmpe-878	81	10	he	he	PRON
ajmpe-878	81	11	underwent	undergo	VERB
ajmpe-878	81	12	tracheostomy	tracheostomy	NOUN
ajmpe-878	81	13	placement	placement	NOUN
ajmpe-878	81	14	.	.	PUNCT
ajmpe-878	82	1	the	the	DET
ajmpe-878	82	2	patient	patient	NOUN
ajmpe-878	82	3	was	be	AUX
ajmpe-878	82	4	taken	take	VERB
ajmpe-878	82	5	off	off	ADP
ajmpe-878	82	6	the	the	DET
ajmpe-878	82	7	ventilator	ventilator	NOUN
ajmpe-878	82	8	on	on	ADP
ajmpe-878	82	9	july	july	PROPN
ajmpe-878	82	10	9th	9th	NOUN
ajmpe-878	82	11	,	,	PUNCT
ajmpe-878	82	12	2022	2022	NUM
ajmpe-878	82	13	,	,	PUNCT
ajmpe-878	82	14	but	but	CCONJ
ajmpe-878	82	15	continued	continue	VERB
ajmpe-878	82	16	to	to	PART
ajmpe-878	82	17	receive	receive	VERB
ajmpe-878	82	18	oxygen	oxygen	NOUN
ajmpe-878	82	19	through	through	ADP
ajmpe-878	82	20	a	a	DET
ajmpe-878	82	21	tracheostomy	tracheostomy	NOUN
ajmpe-878	82	22	.	.	PUNCT
ajmpe-878	83	1	on	on	ADP
ajmpe-878	83	2	august	august	PROPN
ajmpe-878	83	3	1	1	NUM
ajmpe-878	83	4	,	,	PUNCT
ajmpe-878	83	5	2022	2022	NUM
ajmpe-878	83	6	,	,	PUNCT
ajmpe-878	83	7	the	the	DET
ajmpe-878	83	8	patient	patient	NOUN
ajmpe-878	83	9	was	be	AUX
ajmpe-878	83	10	discharged	discharge	VERB
ajmpe-878	83	11	with	with	ADP
ajmpe-878	83	12	stable	stable	ADJ
ajmpe-878	83	13	vital	vital	ADJ
ajmpe-878	83	14	signs	sign	NOUN
ajmpe-878	83	15	.	.	PUNCT
ajmpe-878	84	1	oropharyngeal	oropharyngeal	NOUN
ajmpe-878	84	2	and	and	CCONJ
ajmpe-878	84	3	cardiopulmonary	cardiopulmonary	ADJ
ajmpe-878	84	4	examinations	examination	NOUN
ajmpe-878	84	5	revealed	reveal	VERB
ajmpe-878	84	6	no	no	DET
ajmpe-878	84	7	abnormalities	abnormality	NOUN
ajmpe-878	84	8	.	.	PUNCT
ajmpe-878	85	1	during	during	ADP
ajmpe-878	85	2	neurological	neurological	ADJ
ajmpe-878	85	3	examination	examination	NOUN
ajmpe-878	85	4	,	,	PUNCT
ajmpe-878	85	5	the	the	DET
ajmpe-878	85	6	patient	patient	NOUN
ajmpe-878	85	7	was	be	AUX
ajmpe-878	85	8	spatially	spatially	ADV
ajmpe-878	85	9	and	and	CCONJ
ajmpe-878	85	10	temporally	temporally	ADV
ajmpe-878	85	11	oriented	orient	VERB
ajmpe-878	85	12	and	and	CCONJ
ajmpe-878	85	13	was	be	AUX
ajmpe-878	85	14	able	able	ADJ
ajmpe-878	85	15	to	to	PART
ajmpe-878	85	16	follow	follow	VERB
ajmpe-878	85	17	simple	simple	ADJ
ajmpe-878	85	18	commands	command	NOUN
ajmpe-878	85	19	.	.	PUNCT
ajmpe-878	86	1	pupils	pupil	NOUN
ajmpe-878	86	2	were	be	AUX
ajmpe-878	86	3	equally	equally	ADV
ajmpe-878	86	4	round	round	ADJ
ajmpe-878	86	5	and	and	CCONJ
ajmpe-878	86	6	lightresponsive	lightresponsive	ADJ
ajmpe-878	86	7	.	.	PUNCT
ajmpe-878	87	1	however	however	ADV
ajmpe-878	87	2	,	,	PUNCT
ajmpe-878	87	3	he	he	PRON
ajmpe-878	87	4	still	still	ADV
ajmpe-878	87	5	displayed	display	VERB
ajmpe-878	87	6	dysmetria	dysmetria	NOUN
ajmpe-878	87	7	and	and	CCONJ
ajmpe-878	87	8	babinski	babinski	PROPN
ajmpe-878	87	9	reflex	reflex	NOUN
ajmpe-878	87	10	on	on	ADP
ajmpe-878	87	11	the	the	DET
ajmpe-878	87	12	left	left	ADJ
ajmpe-878	87	13	side	side	NOUN
ajmpe-878	87	14	,	,	PUNCT
ajmpe-878	87	15	along	along	ADP
ajmpe-878	87	16	with	with	ADP
ajmpe-878	87	17	horizontal	horizontal	ADJ
ajmpe-878	87	18	nystagmus	nystagmus	NOUN
ajmpe-878	87	19	,	,	PUNCT
ajmpe-878	87	20	as	as	ADP
ajmpe-878	87	21	residual	residual	ADJ
ajmpe-878	87	22	neurological	neurological	ADJ
ajmpe-878	87	23	deficit	deficit	NOUN
ajmpe-878	87	24	.	.	PUNCT
ajmpe-878	88	1	the	the	DET
ajmpe-878	88	2	patient	patient	NOUN
ajmpe-878	88	3	was	be	AUX
ajmpe-878	88	4	advised	advise	VERB
ajmpe-878	88	5	to	to	PART
ajmpe-878	88	6	take	take	VERB
ajmpe-878	88	7	rifampicin	rifampicin	NOUN
ajmpe-878	88	8	and	and	CCONJ
ajmpe-878	88	9	isoniazid	isoniazid	NOUN
ajmpe-878	88	10	for	for	ADP
ajmpe-878	88	11	9	9	NUM
ajmpe-878	88	12	months	month	NOUN
ajmpe-878	88	13	.	.	PUNCT
ajmpe-878	89	1	ethics	ethic	NOUN
ajmpe-878	89	2	section	section	PROPN
ajmpe-878	89	3	informed	inform	VERB
ajmpe-878	89	4	consent	consent	NOUN
ajmpe-878	89	5	was	be	AUX
ajmpe-878	89	6	obtained	obtain	VERB
ajmpe-878	89	7	from	from	ADP
ajmpe-878	89	8	the	the	DET
ajmpe-878	89	9	patient	patient	NOUN
ajmpe-878	89	10	prior	prior	ADV
ajmpe-878	89	11	to	to	ADP
ajmpe-878	89	12	data	data	NOUN
ajmpe-878	89	13	collection	collection	NOUN
ajmpe-878	89	14	,	,	PUNCT
ajmpe-878	89	15	ensuring	ensure	VERB
ajmpe-878	89	16	their	their	PRON
ajmpe-878	89	17	comprehensive	comprehensive	ADJ
ajmpe-878	89	18	understanding	understanding	NOUN
ajmpe-878	89	19	of	of	ADP
ajmpe-878	89	20	the	the	DET
ajmpe-878	89	21	study	study	NOUN
ajmpe-878	89	22	's	's	PART
ajmpe-878	89	23	objectives	objective	NOUN
ajmpe-878	89	24	,	,	PUNCT
ajmpe-878	89	25	potential	potential	ADJ
ajmpe-878	89	26	implications	implication	NOUN
ajmpe-878	89	27	,	,	PUNCT
ajmpe-878	89	28	and	and	CCONJ
ajmpe-878	89	29	the	the	DET
ajmpe-878	89	30	confidentiality	confidentiality	NOUN
ajmpe-878	89	31	of	of	ADP
ajmpe-878	89	32	their	their	PRON
ajmpe-878	89	33	sensitive	sensitive	ADJ
ajmpe-878	89	34	medical	medical	ADJ
ajmpe-878	89	35	information	information	NOUN
ajmpe-878	89	36	.	.	PUNCT
ajmpe-878	90	1	the	the	DET
ajmpe-878	90	2	patient	patient	NOUN
ajmpe-878	90	3	was	be	AUX
ajmpe-878	90	4	provided	provide	VERB
ajmpe-878	90	5	with	with	ADP
ajmpe-878	90	6	detailed	detailed	ADJ
ajmpe-878	90	7	information	information	NOUN
ajmpe-878	90	8	about	about	ADP
ajmpe-878	90	9	the	the	DET
ajmpe-878	90	10	case	case	NOUN
ajmpe-878	90	11	report	report	NOUN
ajmpe-878	90	12	,	,	PUNCT
ajmpe-878	90	13	including	include	VERB
ajmpe-878	90	14	its	its	PRON
ajmpe-878	90	15	purpose	purpose	NOUN
ajmpe-878	90	16	,	,	PUNCT
ajmpe-878	90	17	methodology	methodology	NOUN
ajmpe-878	90	18	,	,	PUNCT
ajmpe-878	90	19	and	and	CCONJ
ajmpe-878	90	20	the	the	DET
ajmpe-878	90	21	intended	intend	VERB
ajmpe-878	90	22	use	use	NOUN
ajmpe-878	90	23	of	of	ADP
ajmpe-878	90	24	medical	medical	ADJ
ajmpe-878	90	25	records	record	NOUN
ajmpe-878	90	26	and	and	CCONJ
ajmpe-878	90	27	clinical	clinical	ADJ
ajmpe-878	90	28	details	detail	NOUN
ajmpe-878	90	29	.	.	PUNCT
ajmpe-878	91	1	it	it	PRON
ajmpe-878	91	2	was	be	AUX
ajmpe-878	91	3	explicitly	explicitly	ADV
ajmpe-878	91	4	communicated	communicate	VERB
ajmpe-878	91	5	that	that	SCONJ
ajmpe-878	91	6	participation	participation	NOUN
ajmpe-878	91	7	in	in	ADP
ajmpe-878	91	8	the	the	DET
ajmpe-878	91	9	study	study	NOUN
ajmpe-878	91	10	was	be	AUX
ajmpe-878	91	11	entirely	entirely	ADV
ajmpe-878	91	12	voluntary	voluntary	ADJ
ajmpe-878	91	13	,	,	PUNCT
ajmpe-878	91	14	and	and	CCONJ
ajmpe-878	91	15	the	the	DET
ajmpe-878	91	16	patient	patient	NOUN
ajmpe-878	91	17	could	could	AUX
ajmpe-878	91	18	opt	opt	VERB
ajmpe-878	91	19	out	out	ADP
ajmpe-878	91	20	at	at	ADP
ajmpe-878	91	21	any	any	DET
ajmpe-878	91	22	stage	stage	NOUN
ajmpe-878	91	23	without	without	ADP
ajmpe-878	91	24	affecting	affect	VERB
ajmpe-878	91	25	their	their	PRON
ajmpe-878	91	26	medical	medical	ADJ
ajmpe-878	91	27	care	care	NOUN
ajmpe-878	91	28	or	or	CCONJ
ajmpe-878	91	29	rights	right	NOUN
ajmpe-878	91	30	.	.	PUNCT
ajmpe-878	92	1	emphasis	emphasis	NOUN
ajmpe-878	92	2	was	be	AUX
ajmpe-878	92	3	placed	place	VERB
ajmpe-878	92	4	on	on	ADP
ajmpe-878	92	5	the	the	DET
ajmpe-878	92	6	de	de	NOUN
ajmpe-878	92	7	-	-	NOUN
ajmpe-878	92	8	identification	identification	NOUN
ajmpe-878	92	9	of	of	ADP
ajmpe-878	92	10	all	all	DET
ajmpe-878	92	11	data	datum	NOUN
ajmpe-878	92	12	,	,	PUNCT
ajmpe-878	92	13	ensuring	ensure	VERB
ajmpe-878	92	14	the	the	DET
ajmpe-878	92	15	anonymity	anonymity	NOUN
ajmpe-878	92	16	of	of	ADP
ajmpe-878	92	17	the	the	DET
ajmpe-878	92	18	patient	patient	NOUN
ajmpe-878	92	19	.	.	PUNCT
ajmpe-878	93	1	the	the	DET
ajmpe-878	93	2	patient	patient	NOUN
ajmpe-878	93	3	was	be	AUX
ajmpe-878	93	4	reassured	reassure	VERB
ajmpe-878	93	5	that	that	SCONJ
ajmpe-878	93	6	the	the	DET
ajmpe-878	93	7	patient	patient	NOUN
ajmpe-878	93	8	's	's	PART
ajmpe-878	93	9	personal	personal	ADJ
ajmpe-878	93	10	and	and	CCONJ
ajmpe-878	93	11	medical	medical	ADJ
ajmpe-878	93	12	information	information	NOUN
ajmpe-878	93	13	would	would	AUX
ajmpe-878	93	14	be	be	AUX
ajmpe-878	93	15	treated	treat	VERB
ajmpe-878	93	16	with	with	ADP
ajmpe-878	93	17	the	the	DET
ajmpe-878	93	18	utmost	utmost	ADJ
ajmpe-878	93	19	confidentiality	confidentiality	NOUN
ajmpe-878	93	20	and	and	CCONJ
ajmpe-878	93	21	solely	solely	ADV
ajmpe-878	93	22	utilized	utilize	VERB
ajmpe-878	93	23	for	for	ADP
ajmpe-878	93	24	the	the	DET
ajmpe-878	93	25	purpose	purpose	NOUN
ajmpe-878	93	26	of	of	ADP
ajmpe-878	93	27	this	this	DET
ajmpe-878	93	28	case	case	NOUN
ajmpe-878	93	29	report	report	NOUN
ajmpe-878	93	30	.	.	PUNCT
ajmpe-878	94	1	discussion	discussion	NOUN
ajmpe-878	94	2	based	base	VERB
ajmpe-878	94	3	on	on	ADP
ajmpe-878	94	4	this	this	DET
ajmpe-878	94	5	case	case	NOUN
ajmpe-878	94	6	,	,	PUNCT
ajmpe-878	94	7	it	it	PRON
ajmpe-878	94	8	is	be	AUX
ajmpe-878	94	9	apparent	apparent	ADJ
ajmpe-878	94	10	that	that	SCONJ
ajmpe-878	94	11	even	even	ADV
ajmpe-878	94	12	a	a	DET
ajmpe-878	94	13	benign	benign	ADJ
ajmpe-878	94	14	case	case	NOUN
ajmpe-878	94	15	of	of	ADP
ajmpe-878	94	16	covid-19	covid-19	PROPN
ajmpe-878	94	17	may	may	AUX
ajmpe-878	94	18	eventually	eventually	ADV
ajmpe-878	94	19	lead	lead	VERB
ajmpe-878	94	20	to	to	ADP
ajmpe-878	94	21	severe	severe	ADJ
ajmpe-878	94	22	consequences	consequence	NOUN
ajmpe-878	94	23	,	,	PUNCT
ajmpe-878	94	24	such	such	ADJ
ajmpe-878	94	25	as	as	ADP
ajmpe-878	94	26	tb	tb	ADP
ajmpe-878	94	27	reactivation	reactivation	NOUN
ajmpe-878	94	28	.	.	PUNCT
ajmpe-878	95	1	the	the	DET
ajmpe-878	95	2	timely	timely	ADJ
ajmpe-878	95	3	identification	identification	NOUN
ajmpe-878	95	4	of	of	ADP
ajmpe-878	95	5	early	early	ADJ
ajmpe-878	95	6	neurological	neurological	ADJ
ajmpe-878	95	7	manifestations	manifestation	NOUN
ajmpe-878	95	8	allowed	allow	VERB
ajmpe-878	95	9	for	for	ADP
ajmpe-878	95	10	prompt	prompt	ADJ
ajmpe-878	95	11	evaluation	evaluation	NOUN
ajmpe-878	95	12	and	and	CCONJ
ajmpe-878	95	13	diagnosis	diagnosis	NOUN
ajmpe-878	95	14	of	of	ADP
ajmpe-878	95	15	tb	tb	ADP
ajmpe-878	95	16	meningitis	meningitis	NOUN
ajmpe-878	95	17	,	,	PUNCT
ajmpe-878	95	18	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-878	95	19	american	american	PROPN
ajmpe-878	95	20	journal	journal	PROPN
ajmpe-878	95	21	of	of	ADP
ajmpe-878	95	22	medical	medical	ADJ
ajmpe-878	95	23	and	and	CCONJ
ajmpe-878	95	24	physical	physical	ADJ
ajmpe-878	95	25	education	education	NOUN
ajmpe-878	95	26	vol.9	vol.9	PROPN
ajmpe-878	95	27	,	,	PUNCT
ajmpe-878	95	28	issue	issue	NOUN
ajmpe-878	95	29	1	1	NUM
ajmpe-878	95	30	;	;	PUNCT
ajmpe-878	95	31	january	january	PROPN
ajmpe-878	95	32	-	-	PUNCT
ajmpe-878	95	33	february	february	PROPN
ajmpe-878	95	34	2024	2024	NUM
ajmpe-878	95	35	;	;	PUNCT
ajmpe-878	95	36	issn	issn	PROPN
ajmpe-878	95	37	:	:	PUNCT
ajmpe-878	95	38	2994	2994	NUM
ajmpe-878	95	39	-	-	SYM
ajmpe-878	95	40	0524	0524	NUM
ajmpe-878	95	41	impact	impact	NOUN
ajmpe-878	95	42	factor	factor	NOUN
ajmpe-878	95	43	:	:	PUNCT
ajmpe-878	95	44	6.14	6.14	NUM
ajmpe-878	95	45	1252	1252	NUM
ajmpe-878	95	46	columbia	columbia	PROPN
ajmpe-878	95	47	rd	rd	PROPN
ajmpe-878	95	48	nw	nw	PROPN
ajmpe-878	95	49	,	,	PUNCT
ajmpe-878	95	50	washington	washington	PROPN
ajmpe-878	95	51	dc	dc	PROPN
ajmpe-878	95	52	,	,	PUNCT
ajmpe-878	95	53	united	united	PROPN
ajmpe-878	95	54	states	states	PROPN
ajmpe-878	95	55	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	95	56	;	;	PUNCT
ajmpe-878	95	57	mail	mail	NOUN
ajmpe-878	95	58	:	:	PUNCT
ajmpe-878	96	1	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	96	2	4	4	NUM
ajmpe-878	97	1	|	|	ADV
ajmpe-878	97	2	a	a	DET
ajmpe-878	97	3	m	m	NOUN
ajmpe-878	97	4	e	e	NOUN
ajmpe-878	97	5	r	r	NOUN
ajmpe-878	97	6	i	i	NOUN
ajmpe-878	97	7	c	c	VERB
ajmpe-878	97	8	a	a	DET
ajmpe-878	97	9	n	n	NOUN
ajmpe-878	98	1	j	j	NOUN
ajmpe-878	98	2	o	o	X
ajmpe-878	98	3	u	u	NOUN
ajmpe-878	98	4	r	r	NOUN
ajmpe-878	98	5	n	n	NOUN
ajmpe-878	98	6	a	a	DET
ajmpe-878	98	7	l	l	NOUN
ajmpe-878	98	8	o	o	X
ajmpe-878	99	1	f	f	X
ajmpe-878	99	2	m	m	NOUN
ajmpe-878	99	3	e	e	NOUN
ajmpe-878	100	1	d	d	NOUN
ajmpe-878	100	2	i	i	PRON
ajmpe-878	100	3	c	c	VERB
ajmpe-878	100	4	a	a	DET
ajmpe-878	100	5	l	l	NOUN
ajmpe-878	100	6	a	a	X
ajmpe-878	100	7	n	n	NOUN
ajmpe-878	101	1	d	d	NOUN
ajmpe-878	101	2	p	p	NOUN
ajmpe-878	101	3	h	h	NOUN
ajmpe-878	101	4	y	y	NOUN
ajmpe-878	101	5	s	s	VERB
ajmpe-878	102	1	i	i	INTJ
ajmpe-878	102	2	c	c	VERB
ajmpe-878	102	3	a	a	DET
ajmpe-878	102	4	l	l	NOUN
ajmpe-878	102	5	e	e	NOUN
ajmpe-878	102	6	d	d	X
ajmpe-878	102	7	u	u	X
ajmpe-878	102	8	c	c	PROPN
ajmpe-878	103	1	a	a	DET
ajmpe-878	103	2	t	t	NOUN
ajmpe-878	104	1	i	i	PRON
ajmpe-878	104	2	o	o	VERB
ajmpe-878	104	3	n	n	CCONJ
ajmpe-878	104	4	|	|	ADV
ajmpe-878	104	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-878	104	6	figure	figure	NOUN
ajmpe-878	104	7	1	1	NUM
ajmpe-878	104	8	.	.	PUNCT
ajmpe-878	104	9	mri	mri	NOUN
ajmpe-878	104	10	revealed	reveal	VERB
ajmpe-878	104	11	hyperintensity	hyperintensity	NOUN
ajmpe-878	104	12	in	in	ADP
ajmpe-878	104	13	the	the	DET
ajmpe-878	104	14	brainstem	brainstem	NOUN
ajmpe-878	104	15	.	.	PUNCT
ajmpe-878	105	1	figure	figure	NOUN
ajmpe-878	105	2	2	2	NUM
ajmpe-878	105	3	.	.	PUNCT
ajmpe-878	105	4	mri	mri	NOUN
ajmpe-878	105	5	revealed	reveal	VERB
ajmpe-878	105	6	hyperintensity	hyperintensity	NOUN
ajmpe-878	105	7	in	in	ADP
ajmpe-878	105	8	the	the	DET
ajmpe-878	105	9	left	left	ADJ
ajmpe-878	105	10	cerebellum	cerebellum	NOUN
ajmpe-878	105	11	.	.	PUNCT
ajmpe-878	106	1	which	which	PRON
ajmpe-878	106	2	prevented	prevent	VERB
ajmpe-878	106	3	further	further	ADJ
ajmpe-878	106	4	delays	delay	NOUN
ajmpe-878	106	5	in	in	ADP
ajmpe-878	106	6	treatment	treatment	NOUN
ajmpe-878	106	7	.	.	PUNCT
ajmpe-878	107	1	so	so	ADV
ajmpe-878	107	2	,	,	PUNCT
ajmpe-878	107	3	despite	despite	SCONJ
ajmpe-878	107	4	the	the	DET
ajmpe-878	107	5	severity	severity	NOUN
ajmpe-878	107	6	and	and	CCONJ
ajmpe-878	107	7	complexity	complexity	NOUN
ajmpe-878	107	8	of	of	ADP
ajmpe-878	107	9	the	the	DET
ajmpe-878	107	10	presented	present	VERB
ajmpe-878	107	11	case	case	NOUN
ajmpe-878	107	12	,	,	PUNCT
ajmpe-878	107	13	the	the	DET
ajmpe-878	107	14	overall	overall	ADJ
ajmpe-878	107	15	outcome	outcome	NOUN
ajmpe-878	107	16	was	be	AUX
ajmpe-878	107	17	positive	positive	ADJ
ajmpe-878	107	18	.	.	PUNCT
ajmpe-878	108	1	however	however	ADV
ajmpe-878	108	2	,	,	PUNCT
ajmpe-878	108	3	it	it	PRON
ajmpe-878	108	4	should	should	AUX
ajmpe-878	108	5	be	be	AUX
ajmpe-878	108	6	mentioned	mention	VERB
ajmpe-878	108	7	that	that	SCONJ
ajmpe-878	108	8	the	the	DET
ajmpe-878	108	9	patient	patient	NOUN
ajmpe-878	108	10	still	still	ADV
ajmpe-878	108	11	developed	develop	VERB
ajmpe-878	108	12	a	a	DET
ajmpe-878	108	13	residual	residual	ADJ
ajmpe-878	108	14	neurological	neurological	ADJ
ajmpe-878	108	15	deficit	deficit	NOUN
ajmpe-878	108	16	.	.	PUNCT
ajmpe-878	109	1	conclusion	conclusion	NOUN
ajmpe-878	109	2	in	in	ADP
ajmpe-878	109	3	conclusion	conclusion	NOUN
ajmpe-878	109	4	,	,	PUNCT
ajmpe-878	109	5	this	this	DET
ajmpe-878	109	6	case	case	NOUN
ajmpe-878	109	7	highlights	highlight	VERB
ajmpe-878	109	8	that	that	SCONJ
ajmpe-878	109	9	the	the	DET
ajmpe-878	109	10	potential	potential	ADJ
ajmpe-878	109	11	complications	complication	NOUN
ajmpe-878	109	12	and	and	CCONJ
ajmpe-878	109	13	challenges	challenge	NOUN
ajmpe-878	109	14	associated	associate	VERB
ajmpe-878	109	15	with	with	ADP
ajmpe-878	109	16	covid-19	covid-19	PROPN
ajmpe-878	109	17	infection	infection	NOUN
ajmpe-878	109	18	extend	extend	VERB
ajmpe-878	109	19	beyond	beyond	ADP
ajmpe-878	109	20	the	the	DET
ajmpe-878	109	21	impact	impact	NOUN
ajmpe-878	109	22	of	of	ADP
ajmpe-878	109	23	a	a	DET
ajmpe-878	109	24	single	single	ADJ
ajmpe-878	109	25	infectious	infectious	ADJ
ajmpe-878	109	26	megrelishvili	megrelishvili	NOUN
ajmpe-878	109	27	et	et	NOUN
ajmpe-878	109	28	al.3	al.3	PROPN
ajmpe-878	109	29	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-878	109	30	american	american	PROPN
ajmpe-878	109	31	journal	journal	PROPN
ajmpe-878	109	32	of	of	ADP
ajmpe-878	109	33	medical	medical	ADJ
ajmpe-878	109	34	and	and	CCONJ
ajmpe-878	109	35	physical	physical	ADJ
ajmpe-878	109	36	education	education	NOUN
ajmpe-878	109	37	vol.9	vol.9	PROPN
ajmpe-878	109	38	,	,	PUNCT
ajmpe-878	109	39	issue	issue	NOUN
ajmpe-878	109	40	1	1	NUM
ajmpe-878	109	41	;	;	PUNCT
ajmpe-878	109	42	january	january	PROPN
ajmpe-878	109	43	-	-	PUNCT
ajmpe-878	109	44	february	february	PROPN
ajmpe-878	109	45	2024	2024	NUM
ajmpe-878	109	46	;	;	PUNCT
ajmpe-878	109	47	issn	issn	PROPN
ajmpe-878	109	48	:	:	PUNCT
ajmpe-878	109	49	2994	2994	NUM
ajmpe-878	109	50	-	-	SYM
ajmpe-878	109	51	0524	0524	NUM
ajmpe-878	109	52	impact	impact	NOUN
ajmpe-878	109	53	factor	factor	NOUN
ajmpe-878	109	54	:	:	PUNCT
ajmpe-878	109	55	6.14	6.14	NUM
ajmpe-878	109	56	1252	1252	NUM
ajmpe-878	109	57	columbia	columbia	PROPN
ajmpe-878	109	58	rd	rd	PROPN
ajmpe-878	109	59	nw	nw	PROPN
ajmpe-878	109	60	,	,	PUNCT
ajmpe-878	109	61	washington	washington	PROPN
ajmpe-878	109	62	dc	dc	PROPN
ajmpe-878	109	63	,	,	PUNCT
ajmpe-878	109	64	united	united	PROPN
ajmpe-878	109	65	states	states	PROPN
ajmpe-878	109	66	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	109	67	;	;	PUNCT
ajmpe-878	109	68	mail	mail	NOUN
ajmpe-878	109	69	:	:	PUNCT
ajmpe-878	109	70	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	110	1	5	5	NUM
ajmpe-878	111	1	|	|	ADV
ajmpe-878	111	2	a	a	DET
ajmpe-878	111	3	m	m	NOUN
ajmpe-878	111	4	e	e	NOUN
ajmpe-878	111	5	r	r	NOUN
ajmpe-878	111	6	i	i	NOUN
ajmpe-878	111	7	c	c	VERB
ajmpe-878	111	8	a	a	DET
ajmpe-878	111	9	n	n	NOUN
ajmpe-878	112	1	j	j	NOUN
ajmpe-878	112	2	o	o	X
ajmpe-878	112	3	u	u	NOUN
ajmpe-878	112	4	r	r	NOUN
ajmpe-878	112	5	n	n	NOUN
ajmpe-878	112	6	a	a	DET
ajmpe-878	112	7	l	l	NOUN
ajmpe-878	112	8	o	o	X
ajmpe-878	113	1	f	f	X
ajmpe-878	113	2	m	m	NOUN
ajmpe-878	113	3	e	e	NOUN
ajmpe-878	114	1	d	d	NOUN
ajmpe-878	114	2	i	i	PRON
ajmpe-878	114	3	c	c	VERB
ajmpe-878	114	4	a	a	DET
ajmpe-878	114	5	l	l	NOUN
ajmpe-878	114	6	a	a	X
ajmpe-878	114	7	n	n	NOUN
ajmpe-878	115	1	d	d	NOUN
ajmpe-878	115	2	p	p	NOUN
ajmpe-878	115	3	h	h	NOUN
ajmpe-878	115	4	y	y	NOUN
ajmpe-878	115	5	s	s	VERB
ajmpe-878	116	1	i	i	INTJ
ajmpe-878	116	2	c	c	VERB
ajmpe-878	116	3	a	a	DET
ajmpe-878	116	4	l	l	NOUN
ajmpe-878	116	5	e	e	NOUN
ajmpe-878	116	6	d	d	X
ajmpe-878	116	7	u	u	X
ajmpe-878	116	8	c	c	PROPN
ajmpe-878	117	1	a	a	DET
ajmpe-878	117	2	t	t	NOUN
ajmpe-878	118	1	i	i	PRON
ajmpe-878	118	2	o	o	VERB
ajmpe-878	118	3	n	n	CCONJ
ajmpe-878	118	4	|	|	ADV
ajmpe-878	118	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	118	6	agent	agent	NOUN
ajmpe-878	118	7	.	.	PUNCT
ajmpe-878	119	1	the	the	DET
ajmpe-878	119	2	combined	combine	VERB
ajmpe-878	119	3	effects	effect	NOUN
ajmpe-878	119	4	of	of	ADP
ajmpe-878	119	5	multiple	multiple	ADJ
ajmpe-878	119	6	factors	factor	NOUN
ajmpe-878	119	7	can	can	AUX
ajmpe-878	119	8	significantly	significantly	ADV
ajmpe-878	119	9	affect	affect	VERB
ajmpe-878	119	10	various	various	ADJ
ajmpe-878	119	11	organ	organ	NOUN
ajmpe-878	119	12	systems	system	NOUN
ajmpe-878	119	13	,	,	PUNCT
ajmpe-878	119	14	including	include	VERB
ajmpe-878	119	15	the	the	DET
ajmpe-878	119	16	nervous	nervous	ADJ
ajmpe-878	119	17	system	system	NOUN
ajmpe-878	119	18	.	.	PUNCT
ajmpe-878	120	1	covid-19	covid-19	PROPN
ajmpe-878	120	2	affects	affect	VERB
ajmpe-878	120	3	several	several	ADJ
ajmpe-878	120	4	organ	organ	NOUN
ajmpe-878	120	5	systems	system	NOUN
ajmpe-878	120	6	,	,	PUNCT
ajmpe-878	120	7	thus	thus	ADV
ajmpe-878	120	8	any	any	DET
ajmpe-878	120	9	symptom	symptom	NOUN
ajmpe-878	120	10	could	could	AUX
ajmpe-878	120	11	be	be	AUX
ajmpe-878	120	12	attributed	attribute	VERB
ajmpe-878	120	13	to	to	ADP
ajmpe-878	120	14	it	it	PRON
ajmpe-878	120	15	and	and	CCONJ
ajmpe-878	120	16	underlying	underlying	ADJ
ajmpe-878	120	17	pathology	pathology	NOUN
ajmpe-878	120	18	may	may	AUX
ajmpe-878	120	19	go	go	VERB
ajmpe-878	120	20	unnoticed	unnoticed	ADJ
ajmpe-878	120	21	.	.	PUNCT
ajmpe-878	121	1	the	the	DET
ajmpe-878	121	2	immune	immune	ADJ
ajmpe-878	121	3	system	system	NOUN
ajmpe-878	121	4	suppression	suppression	NOUN
ajmpe-878	121	5	induced	induce	VERB
ajmpe-878	121	6	by	by	ADP
ajmpe-878	121	7	covid-19	covid-19	PROPN
ajmpe-878	121	8	can	can	AUX
ajmpe-878	121	9	increase	increase	VERB
ajmpe-878	121	10	the	the	DET
ajmpe-878	121	11	risk	risk	NOUN
ajmpe-878	121	12	of	of	ADP
ajmpe-878	121	13	tb	tb	ADP
ajmpe-878	121	14	reactivation	reactivation	NOUN
ajmpe-878	121	15	,	,	PUNCT
ajmpe-878	121	16	thereby	thereby	ADV
ajmpe-878	121	17	complicating	complicate	VERB
ajmpe-878	121	18	diagnosis	diagnosis	NOUN
ajmpe-878	121	19	and	and	CCONJ
ajmpe-878	121	20	treatment	treatment	NOUN
ajmpe-878	121	21	.	.	PUNCT
ajmpe-878	122	1	therefore	therefore	ADV
ajmpe-878	122	2	,	,	PUNCT
ajmpe-878	122	3	it	it	PRON
ajmpe-878	122	4	is	be	AUX
ajmpe-878	122	5	crucial	crucial	ADJ
ajmpe-878	122	6	to	to	PART
ajmpe-878	122	7	consider	consider	VERB
ajmpe-878	122	8	the	the	DET
ajmpe-878	122	9	possibility	possibility	NOUN
ajmpe-878	122	10	of	of	ADP
ajmpe-878	122	11	tb	tb	ADP
ajmpe-878	122	12	reactivation	reactivation	NOUN
ajmpe-878	122	13	in	in	ADP
ajmpe-878	122	14	covid-19	covid-19	PROPN
ajmpe-878	122	15	patients	patient	NOUN
ajmpe-878	122	16	,	,	PUNCT
ajmpe-878	122	17	particularly	particularly	ADV
ajmpe-878	122	18	those	those	PRON
ajmpe-878	122	19	from	from	ADP
ajmpe-878	122	20	regions	region	NOUN
ajmpe-878	122	21	with	with	ADP
ajmpe-878	122	22	high	high	ADJ
ajmpe-878	122	23	tb	tb	ADP
ajmpe-878	122	24	prevalence	prevalence	NOUN
ajmpe-878	122	25	.	.	PUNCT
ajmpe-878	123	1	therefore	therefore	ADV
ajmpe-878	123	2	,	,	PUNCT
ajmpe-878	123	3	timely	timely	ADJ
ajmpe-878	123	4	detection	detection	NOUN
ajmpe-878	123	5	and	and	CCONJ
ajmpe-878	123	6	prompt	prompt	ADJ
ajmpe-878	123	7	treatment	treatment	NOUN
ajmpe-878	123	8	of	of	ADP
ajmpe-878	123	9	tb	tb	NOUN
ajmpe-878	123	10	are	be	AUX
ajmpe-878	123	11	essential	essential	ADJ
ajmpe-878	123	12	to	to	PART
ajmpe-878	123	13	prevent	prevent	VERB
ajmpe-878	123	14	severe	severe	ADJ
ajmpe-878	123	15	complications	complication	NOUN
ajmpe-878	123	16	and	and	CCONJ
ajmpe-878	123	17	improve	improve	VERB
ajmpe-878	123	18	clinical	clinical	ADJ
ajmpe-878	123	19	outcomes	outcome	NOUN
ajmpe-878	123	20	in	in	ADP
ajmpe-878	123	21	these	these	DET
ajmpe-878	123	22	patients	patient	NOUN
ajmpe-878	123	23	.	.	PUNCT
ajmpe-878	124	1	conflict	conflict	NOUN
ajmpe-878	124	2	of	of	ADP
ajmpe-878	124	3	interests	interest	NOUN
ajmpe-878	124	4	the	the	DET
ajmpe-878	124	5	authors	author	NOUN
ajmpe-878	124	6	have	have	AUX
ajmpe-878	124	7	not	not	PART
ajmpe-878	124	8	declared	declare	VERB
ajmpe-878	124	9	any	any	DET
ajmpe-878	124	10	conflict	conflict	NOUN
ajmpe-878	124	11	of	of	ADP
ajmpe-878	124	12	interests	interest	NOUN
ajmpe-878	124	13	.	.	PUNCT
ajmpe-878	125	1	references	reference	NOUN
ajmpe-878	125	2	centers	center	NOUN
ajmpe-878	125	3	for	for	ADP
ajmpe-878	125	4	disease	disease	NOUN
ajmpe-878	125	5	control	control	NOUN
ajmpe-878	125	6	and	and	CCONJ
ajmpe-878	125	7	prevention	prevention	NOUN
ajmpe-878	125	8	(	(	PUNCT
ajmpe-878	125	9	2022	2022	NUM
ajmpe-878	125	10	)	)	PUNCT
ajmpe-878	125	11	.	.	PUNCT
ajmpe-878	126	1	tuberculosis	tuberculosis	NOUN
ajmpe-878	126	2	(	(	PUNCT
ajmpe-878	126	3	tb	tb	NOUN
ajmpe-878	126	4	)	)	PUNCT
ajmpe-878	126	5	.	.	PUNCT
ajmpe-878	127	1	retrieved	retrieve	VERB
ajmpe-878	127	2	from	from	ADP
ajmpe-878	127	3	https://www.cdc.gov/tb/topic/basics/default.htm	https://www.cdc.gov/tb/topic/basics/default.htm	PROPN
ajmpe-878	127	4	chan	chan	PROPN
ajmpe-878	127	5	kh	kh	PROPN
ajmpe-878	127	6	,	,	PUNCT
ajmpe-878	127	7	cheung	cheung	PROPN
ajmpe-878	127	8	rt	rt	PROPN
ajmpe-878	127	9	,	,	PUNCT
ajmpe-878	127	10	lee	lee	PROPN
ajmpe-878	127	11	r	r	PROPN
ajmpe-878	127	12	(	(	PUNCT
ajmpe-878	127	13	2005	2005	NUM
ajmpe-878	127	14	)	)	PUNCT
ajmpe-878	127	15	.	.	PUNCT
ajmpe-878	128	1	cerebral	cerebral	ADJ
ajmpe-878	128	2	infarcts	infarct	VERB
ajmpe-878	128	3	complicating	complicate	VERB
ajmpe-878	128	4	tuberculous	tuberculous	ADJ
ajmpe-878	128	5	meningitis	meningiti	NOUN
ajmpe-878	128	6	.	.	PUNCT
ajmpe-878	129	1	cerebrovascular	cerebrovascular	ADJ
ajmpe-878	129	2	diseases	disease	NOUN
ajmpe-878	129	3	19:391	19:391	NUM
ajmpe-878	129	4	.	.	PUNCT
ajmpe-878	130	1	dastur	dastur	PROPN
ajmpe-878	130	2	dk	dk	PROPN
ajmpe-878	130	3	,	,	PUNCT
ajmpe-878	130	4	manghani	manghani	PROPN
ajmpe-878	130	5	dk	dk	PROPN
ajmpe-878	130	6	,	,	PUNCT
ajmpe-878	130	7	udani	udani	ADJ
ajmpe-878	130	8	pm	pm	NOUN
ajmpe-878	130	9	(	(	PUNCT
ajmpe-878	130	10	1995	1995	NUM
ajmpe-878	130	11	)	)	PUNCT
ajmpe-878	130	12	.	.	PUNCT
ajmpe-878	131	1	pathology	pathology	NOUN
ajmpe-878	131	2	and	and	CCONJ
ajmpe-878	131	3	pathogenetic	pathogenetic	ADJ
ajmpe-878	131	4	mechanisms	mechanism	NOUN
ajmpe-878	131	5	in	in	ADP
ajmpe-878	131	6	neurotuberculosis	neurotuberculosis	NOUN
ajmpe-878	131	7	.	.	PUNCT
ajmpe-878	132	1	radiologic	radiologic	ADJ
ajmpe-878	132	2	clinics	clinic	NOUN
ajmpe-878	132	3	of	of	ADP
ajmpe-878	132	4	north	north	PROPN
ajmpe-878	132	5	america	america	PROPN
ajmpe-878	132	6	33:733	33:733	NUM
ajmpe-878	132	7	.	.	PUNCT
ajmpe-878	133	1	donald	donald	PROPN
ajmpe-878	133	2	pr	pr	PROPN
ajmpe-878	133	3	(	(	PUNCT
ajmpe-878	133	4	2010	2010	NUM
ajmpe-878	133	5	)	)	PUNCT
ajmpe-878	133	6	.	.	PUNCT
ajmpe-878	134	1	cerebrospinal	cerebrospinal	ADJ
ajmpe-878	134	2	fluid	fluid	ADJ
ajmpe-878	134	3	concentrations	concentration	NOUN
ajmpe-878	134	4	of	of	ADP
ajmpe-878	134	5	antituberculosis	antituberculosis	NOUN
ajmpe-878	134	6	agents	agent	NOUN
ajmpe-878	134	7	in	in	ADP
ajmpe-878	134	8	adults	adult	NOUN
ajmpe-878	134	9	and	and	CCONJ
ajmpe-878	134	10	children	child	NOUN
ajmpe-878	134	11	.	.	PUNCT
ajmpe-878	135	1	tuberculosis	tuberculosis	NOUN
ajmpe-878	135	2	(	(	PUNCT
ajmpe-878	135	3	edinb	edinb	NOUN
ajmpe-878	135	4	)	)	PUNCT
ajmpe-878	135	5	90:279	90:279	NOUN
ajmpe-878	135	6	.	.	PUNCT
ajmpe-878	136	1	lewinsohn	lewinsohn	PROPN
ajmpe-878	136	2	dm	dm	PROPN
ajmpe-878	136	3	,	,	PUNCT
ajmpe-878	136	4	leonard	leonard	PROPN
ajmpe-878	136	5	mk	mk	PROPN
ajmpe-878	136	6	,	,	PUNCT
ajmpe-878	136	7	lobue	lobue	PROPN
ajmpe-878	136	8	pa	pa	PROPN
ajmpe-878	136	9	(	(	PUNCT
ajmpe-878	136	10	2017	2017	NUM
ajmpe-878	136	11	)	)	PUNCT
ajmpe-878	136	12	.	.	PUNCT
ajmpe-878	137	1	official	official	ADJ
ajmpe-878	137	2	american	american	PROPN
ajmpe-878	137	3	thoracic	thoracic	PROPN
ajmpe-878	137	4	society	society	NOUN
ajmpe-878	137	5	/	/	SYM
ajmpe-878	137	6	infectious	infectious	ADJ
ajmpe-878	137	7	diseases	disease	NOUN
ajmpe-878	137	8	society	society	NOUN
ajmpe-878	137	9	of	of	ADP
ajmpe-878	137	10	america	america	PROPN
ajmpe-878	137	11	/	/	SYM
ajmpe-878	137	12	centers	center	NOUN
ajmpe-878	137	13	for	for	ADP
ajmpe-878	137	14	disease	disease	NOUN
ajmpe-878	137	15	control	control	NOUN
ajmpe-878	137	16	and	and	CCONJ
ajmpe-878	137	17	prevention	prevention	NOUN
ajmpe-878	137	18	clinical	clinical	ADJ
ajmpe-878	137	19	practice	practice	NOUN
ajmpe-878	137	20	guidelines	guideline	NOUN
ajmpe-878	137	21	:	:	PUNCT
ajmpe-878	137	22	diagnosis	diagnosis	NOUN
ajmpe-878	137	23	of	of	ADP
ajmpe-878	137	24	tuberculosis	tuberculosis	NOUN
ajmpe-878	137	25	in	in	ADP
ajmpe-878	137	26	adults	adult	NOUN
ajmpe-878	137	27	and	and	CCONJ
ajmpe-878	137	28	children	child	NOUN
ajmpe-878	137	29	.	.	PUNCT
ajmpe-878	138	1	clinical	clinical	ADJ
ajmpe-878	138	2	infectious	infectious	ADJ
ajmpe-878	138	3	diseases	disease	NOUN
ajmpe-878	138	4	64	64	NUM
ajmpe-878	138	5	:	:	PUNCT
ajmpe-878	138	6	e1	e1	NOUN
ajmpe-878	138	7	.	.	PUNCT
ajmpe-878	139	1	navarro	navarro	PROPN
ajmpe-878	139	2	-	-	PUNCT
ajmpe-878	139	3	flores	flores	PROPN
ajmpe-878	139	4	a	a	PRON
ajmpe-878	139	5	,	,	PUNCT
ajmpe-878	139	6	fernandez	fernandez	PROPN
ajmpe-878	139	7	-	-	PUNCT
ajmpe-878	139	8	chinguel	chinguel	PROPN
ajmpe-878	139	9	je	je	PROPN
ajmpe-878	139	10	,	,	PUNCT
ajmpe-878	139	11	pacheco	pacheco	PROPN
ajmpe-878	139	12	-	-	PUNCT
ajmpe-878	139	13	barrios	barrios	PROPN
ajmpe-878	139	14	n	n	CCONJ
ajmpe-878	139	15	(	(	PUNCT
ajmpe-878	139	16	2022	2022	NUM
ajmpe-878	139	17	)	)	PUNCT
ajmpe-878	139	18	.	.	PUNCT
ajmpe-878	140	1	global	global	ADJ
ajmpe-878	140	2	morbidity	morbidity	NOUN
ajmpe-878	140	3	and	and	CCONJ
ajmpe-878	140	4	mortality	mortality	NOUN
ajmpe-878	140	5	of	of	ADP
ajmpe-878	140	6	central	central	ADJ
ajmpe-878	140	7	nervous	nervous	ADJ
ajmpe-878	140	8	system	system	NOUN
ajmpe-878	140	9	tuberculosis	tuberculosis	NOUN
ajmpe-878	140	10	:	:	PUNCT
ajmpe-878	140	11	a	a	DET
ajmpe-878	140	12	systematic	systematic	ADJ
ajmpe-878	140	13	review	review	NOUN
ajmpe-878	140	14	and	and	CCONJ
ajmpe-878	140	15	meta	meta	ADJ
ajmpe-878	140	16	-	-	PUNCT
ajmpe-878	140	17	analysis	analysis	NOUN
ajmpe-878	140	18	.	.	PUNCT
ajmpe-878	141	1	the	the	DET
ajmpe-878	141	2	journal	journal	NOUN
ajmpe-878	141	3	of	of	ADP
ajmpe-878	141	4	neurology	neurology	NOUN
ajmpe-878	141	5	269:3482	269:3482	PROPN
ajmpe-878	141	6	.	.	PUNCT
ajmpe-878	142	1	poltera	poltera	NOUN
ajmpe-878	142	2	aa	aa	NOUN
ajmpe-878	142	3	(	(	PUNCT
ajmpe-878	142	4	1977	1977	NUM
ajmpe-878	142	5	)	)	PUNCT
ajmpe-878	142	6	.	.	PUNCT
ajmpe-878	143	1	thrombogenic	thrombogenic	ADJ
ajmpe-878	143	2	intracranial	intracranial	NOUN
ajmpe-878	143	3	vasculitis	vasculiti	VERB
ajmpe-878	143	4	in	in	ADP
ajmpe-878	143	5	tuberculous	tuberculous	ADJ
ajmpe-878	143	6	meningitis	meningitis	NOUN
ajmpe-878	143	7	.	.	PUNCT
ajmpe-878	144	1	a	a	DET
ajmpe-878	144	2	20	20	NUM
ajmpe-878	144	3	year	year	NOUN
ajmpe-878	144	4	"	"	PUNCT
ajmpe-878	144	5	post	post	NOUN
ajmpe-878	144	6	mortem	mortem	NOUN
ajmpe-878	144	7	"	"	PUNCT
ajmpe-878	144	8	survey	survey	NOUN
ajmpe-878	144	9	.	.	PUNCT
ajmpe-878	145	1	acta	acta	PROPN
ajmpe-878	145	2	neurologica	neurologica	PROPN
ajmpe-878	145	3	belgica	belgica	PROPN
ajmpe-878	145	4	77:12	77:12	NUM
ajmpe-878	145	5	.	.	PUNCT
ajmpe-878	146	1	rich	rich	PROPN
ajmpe-878	146	2	ar	ar	PROPN
ajmpe-878	146	3	,	,	PUNCT
ajmpe-878	146	4	mccordock	mccordock	ADJ
ajmpe-878	146	5	ha	ha	INTJ
ajmpe-878	146	6	(	(	PUNCT
ajmpe-878	146	7	1933	1933	NUM
ajmpe-878	146	8	)	)	PUNCT
ajmpe-878	146	9	.	.	PUNCT
ajmpe-878	147	1	pathogenesis	pathogenesis	NOUN
ajmpe-878	147	2	of	of	ADP
ajmpe-878	147	3	tuberculous	tuberculous	ADJ
ajmpe-878	147	4	meningitis	meningiti	NOUN
ajmpe-878	147	5	.	.	PUNCT
ajmpe-878	148	1	bulletin	bulletin	NOUN
ajmpe-878	148	2	of	of	ADP
ajmpe-878	148	3	the	the	DET
ajmpe-878	148	4	johns	johns	PROPN
ajmpe-878	148	5	hopkins	hopkins	PROPN
ajmpe-878	148	6	hospital	hospital	PROPN
ajmpe-878	148	7	52:5	52:5	NUM
ajmpe-878	148	8	.	.	PUNCT
ajmpe-878	149	1	world	world	PROPN
ajmpe-878	149	2	health	health	PROPN
ajmpe-878	149	3	organization	organization	NOUN
ajmpe-878	149	4	(	(	PUNCT
ajmpe-878	149	5	2017	2017	NUM
ajmpe-878	149	6	)	)	PUNCT
ajmpe-878	149	7	.	.	PUNCT
ajmpe-878	150	1	guidelines	guideline	NOUN
ajmpe-878	150	2	for	for	ADP
ajmpe-878	150	3	treatment	treatment	NOUN
ajmpe-878	150	4	of	of	ADP
ajmpe-878	150	5	drugsusceptible	drugsusceptible	ADJ
ajmpe-878	150	6	tuberculosis	tuberculosis	NOUN
ajmpe-878	150	7	and	and	CCONJ
ajmpe-878	150	8	patient	patient	ADJ
ajmpe-878	150	9	care	care	NOUN
ajmpe-878	150	10	,	,	PUNCT
ajmpe-878	150	11	update	update	NOUN
ajmpe-878	150	12	.	.	PUNCT
ajmpe-878	151	1	http://apps.who.int/iris/bitstream/10665/255052/1/9789241550000eng.pdf?ua=1	http://apps.who.int/iris/bitstream/10665/255052/1/9789241550000eng.pdf?ua=1	NOUN
ajmpe-878	151	2	(	(	PUNCT
ajmpe-878	151	3	accessed	access	VERB
ajmpe-878	151	4	on	on	ADP
ajmpe-878	151	5	june	june	PROPN
ajmpe-878	151	6	08	08	NUM
ajmpe-878	151	7	,	,	PUNCT
ajmpe-878	151	8	2017	2017	NUM
ajmpe-878	151	9	)	)	PUNCT
ajmpe-878	151	10	.	.	PUNCT
ajmpe-878	152	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-878	152	2	american	american	PROPN
ajmpe-878	152	3	journal	journal	PROPN
ajmpe-878	152	4	of	of	ADP
ajmpe-878	152	5	medical	medical	ADJ
ajmpe-878	152	6	and	and	CCONJ
ajmpe-878	152	7	physical	physical	ADJ
ajmpe-878	152	8	education	education	NOUN
ajmpe-878	152	9	vol.9	vol.9	PROPN
ajmpe-878	152	10	,	,	PUNCT
ajmpe-878	152	11	issue	issue	NOUN
ajmpe-878	152	12	1	1	NUM
ajmpe-878	152	13	;	;	PUNCT
ajmpe-878	152	14	january	january	PROPN
ajmpe-878	152	15	-	-	PUNCT
ajmpe-878	152	16	february	february	PROPN
ajmpe-878	152	17	2024	2024	NUM
ajmpe-878	152	18	;	;	PUNCT
ajmpe-878	152	19	issn	issn	PROPN
ajmpe-878	152	20	:	:	PUNCT
ajmpe-878	152	21	2994	2994	NUM
ajmpe-878	152	22	-	-	SYM
ajmpe-878	152	23	0524	0524	NUM
ajmpe-878	152	24	impact	impact	NOUN
ajmpe-878	152	25	factor	factor	NOUN
ajmpe-878	152	26	:	:	PUNCT
ajmpe-878	152	27	6.14	6.14	NUM
ajmpe-878	152	28	1252	1252	NUM
ajmpe-878	152	29	columbia	columbia	PROPN
ajmpe-878	152	30	rd	rd	PROPN
ajmpe-878	152	31	nw	nw	PROPN
ajmpe-878	152	32	,	,	PUNCT
ajmpe-878	152	33	washington	washington	PROPN
ajmpe-878	152	34	dc	dc	PROPN
ajmpe-878	152	35	,	,	PUNCT
ajmpe-878	152	36	united	united	PROPN
ajmpe-878	152	37	states	states	PROPN
ajmpe-878	152	38	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	VERB
ajmpe-878	152	39	;	;	PUNCT
ajmpe-878	152	40	mail	mail	NOUN
ajmpe-878	152	41	:	:	PUNCT
ajmpe-878	152	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-878	153	1	6	6	NUM
ajmpe-878	154	1	|	|	ADV
ajmpe-878	154	2	a	a	DET
ajmpe-878	154	3	m	m	NOUN
ajmpe-878	154	4	e	e	NOUN
ajmpe-878	154	5	r	r	NOUN
ajmpe-878	154	6	i	i	NOUN
ajmpe-878	154	7	c	c	VERB
ajmpe-878	154	8	a	a	DET
ajmpe-878	154	9	n	n	NOUN
ajmpe-878	155	1	j	j	NOUN
ajmpe-878	155	2	o	o	X
ajmpe-878	155	3	u	u	NOUN
ajmpe-878	155	4	r	r	NOUN
ajmpe-878	155	5	n	n	NOUN
ajmpe-878	155	6	a	a	DET
ajmpe-878	155	7	l	l	NOUN
ajmpe-878	155	8	o	o	X
ajmpe-878	156	1	f	f	X
ajmpe-878	156	2	m	m	NOUN
ajmpe-878	156	3	e	e	NOUN
ajmpe-878	157	1	d	d	NOUN
ajmpe-878	157	2	i	i	PRON
ajmpe-878	157	3	c	c	VERB
ajmpe-878	157	4	a	a	DET
ajmpe-878	157	5	l	l	NOUN
ajmpe-878	157	6	a	a	X
ajmpe-878	157	7	n	n	NOUN
ajmpe-878	158	1	d	d	NOUN
ajmpe-878	158	2	p	p	NOUN
ajmpe-878	158	3	h	h	NOUN
ajmpe-878	158	4	y	y	NOUN
ajmpe-878	158	5	s	s	VERB
ajmpe-878	159	1	i	i	INTJ
ajmpe-878	159	2	c	c	VERB
ajmpe-878	159	3	a	a	DET
ajmpe-878	159	4	l	l	NOUN
ajmpe-878	159	5	e	e	NOUN
ajmpe-878	159	6	d	d	X
ajmpe-878	159	7	u	u	X
ajmpe-878	159	8	c	c	PROPN
ajmpe-878	160	1	a	a	DET
ajmpe-878	160	2	t	t	NOUN
ajmpe-878	161	1	i	i	PRON
ajmpe-878	161	2	o	o	VERB
ajmpe-878	161	3	n	n	CCONJ
ajmpe-878	161	4	|	|	ADV
ajmpe-878	161	5	https://topjournals.org/index.php/ajmpe	https://topjournals.org/index.php/ajmpe	NUM
ajmpe-878	161	6	world	world	PROPN
ajmpe-878	161	7	health	health	PROPN
ajmpe-878	161	8	organization	organization	NOUN
ajmpe-878	161	9	(	(	PUNCT
ajmpe-878	161	10	2022a	2022a	NUM
ajmpe-878	161	11	)	)	PUNCT
ajmpe-878	161	12	.	.	PUNCT
ajmpe-878	162	1	global	global	ADJ
ajmpe-878	162	2	tuberculosis	tuberculosis	NOUN
ajmpe-878	162	3	report	report	NOUN
ajmpe-878	162	4	2022	2022	NUM
ajmpe-878	162	5	.	.	PUNCT
ajmpe-878	163	1	retrieved	retrieve	VERB
ajmpe-878	163	2	fromhttps://www.who.int/publications/i/item/9789240061729	fromhttps://www.who.int/publications/i/item/9789240061729	ADJ
ajmpe-878	163	3	world	world	PROPN
ajmpe-878	163	4	health	health	NOUN
ajmpe-878	163	5	organization	organization	NOUN
ajmpe-878	163	6	(	(	PUNCT
ajmpe-878	163	7	2022b	2022b	NUM
ajmpe-878	163	8	)	)	PUNCT
ajmpe-878	163	9	.	.	PUNCT
ajmpe-878	164	1	tb	tb	ADP
ajmpe-878	164	2	disease	disease	NOUN
ajmpe-878	164	3	burden	burden	NOUN
ajmpe-878	164	4	.	.	PUNCT
ajmpe-878	165	1	in	in	ADP
ajmpe-878	165	2	global	global	ADJ
ajmpe-878	165	3	tuberculosis	tuberculosis	NOUN
ajmpe-878	165	4	report	report	NOUN
ajmpe-878	165	5	2022	2022	NUM
ajmpe-878	165	6	.	.	PUNCT
ajmpe-878	166	1	retrieved	retrieve	VERB
ajmpe-878	166	2	from	from	ADP
ajmpe-878	166	3	https://www.who.int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2022/tbdisease-burden/2-2-tbmortality	https://www.who.int/teams/global-tuberculosis-programme/tbreports/global-tuberculosis-report-2022/tbdisease-burden/2-2-tbmortality	NOUN
ajmpe-878	166	4	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN